%PDF-1.3 % 1 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T04PI2P0T5T0q-Br44C@B 9 s (P endstream endobj 4 0 obj <>>>/BBox[0 0 612 792]/Length 55>>stream xs w3T04PI2P0T5T0P02S04S  @$P5 )1 endstream endobj 9 0 obj <>>>/BBox[0 0 612 792]/Length 54>>stream xs w3T04PI2P0T5TR Ɩf !\!Y\ !p)P endstream endobj 3 0 obj <>>>/BBox[0 0 612 792]/Length 54>>stream xs w3T04PI2P0T5TR Ɩf !\!Y\ !p)P endstream endobj 6 0 obj <>>>/BBox[0 0 612 792]/Length 54>>stream xs w3T04PI2P0T5TR Ɩf !\!Y\ !p)P endstream endobj 10 0 obj <>>>/BBox[0 0 612 792]/Length 55>>stream xs w3T04PI2P0T5T0P02S04S  @$P5 )1 endstream endobj 8 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T04PI2P0T5T0q-Br44C@B 9 s (P endstream endobj 7 0 obj <>>>/BBox[0 0 612 792]/Length 55>>stream xs w3T04PI2P0T5T0P02S04S  @$P5 )1 endstream endobj 5 0 obj <>>>/BBox[0 0 612 792]/Length 53>>stream xs w3T04PI2P0T5T0q-Br44C@B 9 s (P endstream endobj 12 0 obj <>stream Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT Arbortext Advanced Print Publisher 9.0.114/W 2017-06-03T00:50:26-07:00 2017-05-29T11:46:13+05:30 application/pdf MDR-2016-0229-ver9-Goic-Barisic_3P 494..496 uuid:6d17b778-b892-43e1-8f76-a4beb23f989b uuid:4f411e87-8e67-488e-8503-5cb9852591d4 endstream endobj 13 0 obj <>stream x+| endstream endobj 14 0 obj <>stream xS**T0T0BiUD* 8 endstream endobj 15 0 obj <>stream x+| endstream endobj 16 0 obj <>stream xS**T0T0BiU)D* 9V endstream endobj 17 0 obj <>stream x+| endstream endobj 18 0 obj <>stream xS**T0T0BiUD* : endstream endobj 20 0 obj <>stream /GS1 gs BT /F5 1 Tf 9.843 0 0 9.843 59.7543 439.4267 Tm 0 0 0 rg 0 Tc 0 Tw (42)Tj /F10 1 Tf 1.0022 0 TD ()Tj /F5 1 Tf .3974 0 TD [(C/48)-166.8(hr)-468.7(on)-468.7(CHROMagar)]TJ /F4 1 Tf 10.7361 0 TD (Acinetobacter)Tj /F5 1 Tf 6.1053 0 TD (\(CHROMagar\))Tj -18.241 -1.1116 TD [(supplement)-8.9(ed)-360.5(with)-368.4(CR102)-364.7(and)-367.3(15)-163.5(mg/L)-364.1(cefsulodin)-370.5(sodium)]TJ T* [(sa)14.1(lt)-503.6(hy)20.8(dr)20.9(at)13.8(e)-514.9(\()0(S)21(i)0(g)20.7(m)0(a)18.4(-)0(A)14.2(l)0(d)20.7(r)0(i)20.7(c)0(h)19.7(\))0(.)-505.6(I)0(d)20.9(e)0(n)19.7(t)0(i)14.8()0(c)19.8(a)0(t)19.5(i)0(o)20.7(n)-519.5(of)-503.3(is)20.9(ol)20.7(at)13.8(e)-514.9(w)0(a)18.8(s)]TJ 0 -1.1174 TD [(pe)13.9(rf)20.9(or)20.9(me)18.4(d)-577.1(b)0(y)-560.9(r)0(o)20.9(u)0(t)15(i)0(n)20.7(e)-572.5(ba)13.9(ct)19.6(er)19.7(io)20.7(lo)20.7(gi)20.7(ca)12.8(l)-571.4(t)0(e)19.6(c)0(h)19.7(n)0(i)15(q)0(u)20.8(e)0(s)19.9(,)-573.6(Vi)19.8(te)13.8(k)-571.3(2)]TJ 0 -1.1116 TD [(sy)15.3(st)20.9(em)-384.7(\(B)19.8(io)20.7(Me)13(ri)20.7(eu)19.7(x\))20.9(,)-395.1(a)0(n)19.7(d)-392.8(MA)13.3(LD)18.8(I-)20.9(TO)18.8(F)-392.6(M)0(S)-388.8(\()0(s)21.1(o)0(f)20.9(t)0(w)19.8(a)0(r)19.7(e)-399.7(ve)19.7(r-)]TJ T* [(si)15.1(on)-307.5(3.)18.5(0,)-309.8(Mi)19.8(cr)19.7(o)21(ex)-308.6(LT)18.5(;)-318(B)0(r)14.1(u)0(k)20.8(e)0(r)-308.6(D)0(a)18.8(l)0(t)20.6(o)0(n)15.1(i)0(c)19.6(s)0(\))-307.2(o)0(n)-307.5(c)0(e)18.5(l)0(l)-313.5(e)0(x)19.7(t)0(r)20.7(a)0(c)18.5(t)0(s)15.1(.)]TJ 7.3823 0 0 6.5614 291.5716 389.0266 Tm (11)Tj 9.843 0 0 9.843 59.7543 373.7196 Tm [(Mo)19.9(le)13.8(cu)19.7(la)19.5(r)-283.3(i)0(d)20.7(e)0(n)19.7(t)0(i)20.6()0(c)14.1(a)0(t)19.5(i)0(o)20.7(n)-283.3(wa)18.8(s)-283.1(p)0(e)19.7(r)0(f)20.9(o)0(r)15.1(m)0(e)18.4(d)-277.6(by)-272.9(am)18.5(pl)14.9(i)20.9(ca)18.5(ti)20.6(on)-272.9(of)-272.9(a)]TJ 0 -1.1174 TD [(fr)15.1(ag)19.7(me)18.4(nt)-278.8(of)]TJ /F4 1 Tf 4.9649 0 TD [(rp)21(o)]TJ /F5 1 Tf 1.3535 0 TD [(B)-295.9(g)0(e)19.7(n)0(e)-279.8(e)0(n)13.9(c)0(o)19.7(d)0(i)20.7(n)0(g)-278.7(R)0(N)13.2(A)-289.9(po)20.8(ly)20.7(me)18.4(ra)14(se)]TJ /F6 1 Tf 14.2207 0 TD (b)Tj /F5 1 Tf .5414 0 TD [(-s)15.3(ub)20.8(un)20.8(it)]TJ -21.0805 -1.1116 TD [(by)-583.9(us)21(in)20.7(g)]TJ /F4 1 Tf 4.3025 0 TD [(rp)21(o)]TJ /F5 1 Tf 1.3535 0 TD (B)Tj /F10 1 Tf .6566 0 TD (+)Tj /F5 1 Tf .5414 0 TD [(16)15.1(27)20.8(/)]TJ /F4 1 Tf 2.2348 0 TD [(rp)21(o)]TJ /F5 1 Tf 1.3535 0 TD [(B-)19.8(22)15.1(31)-578.2(pr)20.9(im)13.7(er)-579.3(pa)19.7(ir)15(.)]TJ 7.3823 0 0 6.5614 246.444 356.1448 Tm (12)Tj 9.843 0 0 9.843 259.5968 351.7794 Tm [(Am)18.7(pl)20.7(i)20.9(ed)]TJ -20.303 -1.1116 TD [(fr)15.1(ag)19.7(me)18.4(nt)20.7(s)-277.4(w)0(e)18.8(r)0(e)-268.3(s)0(e)19.9(q)0(u)20.8(e)0(n)13.9(c)0(e)18.5(d)0(,)-263.7(e)0(d)19.7(i)0(t)20.6(e)0(d)13.9(,)-274.1(an)19.7(d)-277.6(a)0(n)19.7(a)0(l)19.5(y)0(z)19.7(e)0(d)-268.3(a)0(s)-268.1(d)0(e)19.7(s)0(c)14.1(r)0(i)20.7(b)0(e)19.7(d)]TJ 0 -1.1174 TD [(pr)15.1(ev)19.7(io)20.7(us)21(ly)20.7(.)]TJ 7.3823 0 0 6.5614 102.7842 334.2613 Tm (9)Tj 9.843 0 0 9.843 69.7323 318.8976 Tm -.0217 Tc [(S)-5.4(u).2(sc)-6.7(ept)-5.6(i).1(bi)-5.6(lit)-5.6(y)-155.3(t).1(es)-5.3(ti)-5.6(ng)-155.3(was)-155.1(d)-5.5(one)-156.4(by)-155.3(u)-5.5(s).4(in)-5.5(g)-155.3(V)-.6(it)-5.6(ek)-155.3(2)-155.3(s).4(y)-5.5(s).4(te)-6.7(m)-150.7(a)-6.7(nd)]TJ /F4 1 Tf 22.3534 0 TD 0 Tc (E)Tj /F5 1 Tf .5932 0 TD (-)Tj -23.9604 -1.1116 TD -.0216 Tc [(t)-5.5(e)-.8(s)-5.2(t).2(,)-359.1(a)-.8(nd)-362.5(min)-5.4(i).2(mum)-358(i)-5.5(nh)-5.4(ibi)-5.5(t).2(or)-5.4(y)-356.8(c)-.8(o)-5.4(n).3(ce)-6.6(ntr)-5.4(a)-.8(ti)-5.5(on)-5.4(s)-356.6(\().4(M)-6.3(I).4(Cs)-5.2(\))-356.7(w)-.5(e)-6.6(r).4(e)-357.9(i)-5.5(n-)]TJ 0 -1.1174 TD -.0201 Tc [(terpre)-5.1(ted)-349.5(acc)-5.1(ording)-343.7(to)-349.5(EU)-4.8(CAST)-344.9(and)-343.7(C)-4.9(LSI)-349.5(c).7(rite)-5.1(ria)]TJ 7.3823 0 0 6.5614 255.9684 301.3795 Tm -.0294 Tc [(13)-5.5(,1)-5.5(4)]TJ 9.843 0 0 9.843 275.0172 296.9574 Tm -.0219 Tc [(fo)-5.7(r)-345.5(a)-6.9(ll)]TJ -21.8696 -1.1116 TD [(a)-6.8(n).1(ti)-5.7(bi)-5.7(oti)-5.7(c)-1(s)-264.6(w)-.7(it)-5.7(h)-259(d)-5.6(en)-5.6(e)-1(d)-264.8(b).1(re)-6.8(akp)-5.6(o).1(in)-5.6(ts)-264.6(fo)-5.6(r)]TJ /F4 1 Tf 15.3669 0 TD -.0216 Tc [(A)-6.6(c)-.8(in)-5.4(eto)-5.4(bac)-6.6(ter)]TJ /F5 1 Tf 5.6388 0 TD [(sp)-5.4(p.,)-261.2(e)-6.6(x-)]TJ -21.0056 -1.1116 TD [(c)-6.5(e)-.7(pt)-235.8(t)-5.4(i).3(ge)-6.5(cyc)-6.5(lin)-5.3(e)-231.1(w)-6.2(her)-5.3(e)-236.9(bre)-6.5(a)-.7(kp)-5.3(oin)-5.3(t).3(s)-235.5(f).5(o)-5.3(r)-235.7(Ent)-5.4(e)-.7(ro)-5.3(bac)-6.5(t).3(er)-5.3(iac)-6.5(eae)-236.9(we)-6.5(re)]TJ T* [(u)-5.3(s).6(e)-6.5(d).4(.)-157.4(T)-.7(he)-162(pre)-6.5(s).6(en)-5.3(ce)-156.2(o)-5.3(f)-155(ge)-6.5(nes)-160.6(o).4(f)]TJ /F4 1 Tf 11.5367 0 TD -.0162 Tc [(bl)5.6(a)]TJ /F5 1 Tf 7.3823 0 0 6.5614 185.3858 262.4881 Tm -.0268 Tc (OXA)Tj 9.843 0 0 9.843 202.2236 264.1322 Tm -.0214 Tc [(l)-5.3(i).4(n)-5.2(eag)-5.2(e)-156.1(t).4(ha)-6.4(t)-155.1(e)-.6(n)-5.2(c)-.6(od)-5.2(e)-156.1(O)-.3(X)-6.1(A)-.3(-)]TJ -14.4741 -1.1174 TD -.0206 Tc [(type)-414.5(c)-5.6(a).2(rbape)-5.6(n)1.3(em)-5.6(ase)-5.6(s)-413.2(was)-418.9(s)1.5(ea)-5.6(rched)-413.4(b)1.3(y)-413.4(m)-5.6(ultiplex)-413.4(polym)-5.6(e).2(ra)-5.6(se)]TJ 0 -1.1116 TD -.0196 Tc [(c)-4.6(h)2.3(ain)-395.1(r)2.4(ea)-4.6(ction)-395.1(\()-3.4(PCR)-4.4(\))-395(with)-395.1(spe)-4.6(c)1.2(ic)-396.2(p)2.3(rimers)-394.9(for)]TJ /F4 1 Tf 19.0358 0 TD -.0219 Tc (bla)Tj /F5 1 Tf 7.3823 0 0 6.5614 259.1432 240.548 Tm -.0245 Tc [(OXA-5)7(1-like)]TJ 9.843 0 0 9.843 296.3905 242.1921 Tm 0 Tc (,)Tj /F4 1 Tf -24.041 -1.1116 TD -.0162 Tc [(bl)5.6(a)]TJ /F5 1 Tf 7.3823 0 0 6.5614 71.7732 229.6062 Tm -.0258 Tc [(O)-6.6(XA-40-like)]TJ 9.843 0 0 9.843 109.0771 231.2503 Tm 0 Tc (,)Tj /F4 1 Tf .4838 0 TD -.0219 Tc (bla)Tj /F5 1 Tf 7.3823 0 0 6.5614 125.8582 229.6062 Tm -.0278 Tc [(OXA)-8.6(-23-li)-7.9(ke)]TJ 9.843 0 0 9.843 163.1055 231.2503 Tm .2338 Tc [(,a)254.6(n)255.7(d)]TJ /F4 1 Tf 2.1196 0 TD -.0219 Tc [(bl)-5.8(a)]TJ /F5 1 Tf 7.3823 0 0 6.5614 195.9873 229.6062 Tm -.0259 Tc [(OX)-6.7(A-58-like)]TJ 9.843 0 0 9.843 235.7291 231.2503 Tm -.0185 Tc [(gen)3.4(e)-3.5(s)3.6(.)]TJ 7.3823 0 0 6.5614 259.4834 235.6157 Tm -.0239 Tc (15)Tj /F8 1 Tf 8.9663 0 0 8.9663 59.7543 204.4913 Tm 0 Tc [(Results)-337.2(and)-331.9(Discussion)]TJ /F5 1 Tf 9.843 0 0 9.843 69.7323 188.0503 Tm [(The)-408.8(isolate)-413.4(of)]TJ /F4 1 Tf 6.2435 0 TD [(A.)-408.9(baumannii)]TJ /F5 1 Tf 5.9613 0 TD [(named)-406.5(EF7)-407.5(was)-414.1(recovered)]TJ -13.2185 -1.1116 TD [(from)-356.9(0.5)-166.9(ml)-349.1(of)-353.5(the)-355.9(secondary)-353(treated)-357(municipal)-359.4(wastewater)]TJ 25.5097 55.6791 TD [(of)-261.4(the)-269.5(City)-264.9(of)-261.4(Zagreb.)-267(By)-268.2(phenotypical)-270.5(analyses)-265.5(and)-269.4(Vitek)-261.2(2)]TJ 0 -1.1174 TD [(system,)-403.8(the)-396.3(isolate)-407.7(was)-402.6(determined)-401.9(as)]TJ /F4 1 Tf 16.1905 0 TD [(A.)-403.1(calcoaceticusA.)]TJ -16.1905 -1.1116 TD (baumannii)Tj /F5 1 Tf 4.7863 0 TD [(complex.)-504.4(MALDI-TOF)-505.2(MS)-504(analysis)-506.3(gave)-507.8(the)]TJ -4.7863 -1.1116 TD [(score)-341.7(value)-342(of)-342(2.150,)-345.3(which)-341.7(indicates)-347.7(the)-338.7(secure)-343.9(genus)-346.3(and)]TJ T* [(probable)-299.2(species)-304.7(identication.)-304(Phylogeneti)-8.9(c)-296(analysis)-304.7(of)-301.7(the)]TJ /F6 1 Tf 0 -1.1174 TD (*)Tj /F5 1 Tf .9964 0 TD [(600)-170.3(bp)-405.4(fragment)-409.9(of)]TJ /F4 1 Tf 8.3516 0 TD (rpo)Tj /F5 1 Tf 1.3823 0 TD [(B)-411.1(gene)-409.9(conrmed)-409.6(the)-407.8(identica-)]TJ -10.7303 -1.1116 TD [(tion)-269.6(of)-267.1(isolate)-275.2(as)]TJ /F4 1 Tf 6.9289 0 TD [(A.)-270.7(baumannii)]TJ /F5 1 Tf 5.6848 0 TD [(with)-276.2(100%)-264.7(sequence)-278.2(identity)]TJ -12.6138 -1.1116 TD [(\(KX468061\))-675.1(to)-670.5(the)-672.7(reference)-678(sequence)-675.6(from)-673.7(GenBank)]TJ 0 -1.1174 TD (\(CP007535\).)Tj 1.0137 -1.1116 TD -.0216 Tc [(The)-277.3(i).2(s)-5.2(o).3(la)-6.6(te)-277.3(wa)-6.6(s)-270.2(r)-5.4(es)-5.2(ist)-5.6(a)-.8(nt)-276.3(t)-5.5(o)-270.4(a)-6.6(l).2(l)-276.3(t).2(e)-6.6(s).5(t)-5.5(e)-.8(d)-276.1(a)-.8(nt)-5.6(ibi)-5.6(o).3(ti)-5.5(cs)-275.9(\(p)-5.4(en)-5.4(ici)-5.6(lli)-5.5(ns/)]TJ /F6 1 Tf -1.0137 -1.1116 TD 0 Tc (b)Tj /F5 1 Tf .5299 0 TD -.0215 Tc [(-)-5.3(l).3(ac)-6.5(tama)-6.5(se)-513.3(in)-5.3(hib)-5.3(ito)-5.3(rs)-5.1(,)-508.7(car)-5.3(ba)-6.5(pen)-5.3(e)-.7(ms)-5.1(,)-508.7().6(u)-5.3(o).4(ro)-5.3(qui)-5.4(nol)-5.5(on)-5.3(es,)-514.5(a)-.7(mi-)]TJ -.5299 -1.1174 TD -.0218 Tc [(nog)-5.6(ly)-5.6(cos)-5.4(i)0(de)-6.8(s,)-388.1(fol)-5.7(a)-1(te)-386.9(pa)-6.8(thw)-6.5(a)-1(y)-385.8(i)0(n)-5.6(h).1(ib)-5.6(ito)-5.6(rs)-5.4(,)-382.3(a)-1(n)-5.6(d)-380(p)-5.6(o).1(ly)-5.6(myx)-5.6(i)0(ns)-5.4(\))-385.7(e)-1(x-)]TJ 0 -1.1116 TD -.0215 Tc [(cep)-5.3(t)-316.5(i)-5.4(nte)-6.5(r).5(med)-5.3(i).3(a)-6.5(t).3(el)-5.4(y)-316.3(s).6(u)-5.3(s).6(c)-6.5(e)-.7(pt)-5.4(ibl)-5.5(e)-317.5(to)-322.1(te)-6.5(tra)-6.5(c)-.7(yc)-6.5(lin)-5.3(es)-316.1(\()-5.3(T)-.8(ab)-5.3(le)-323.3(1\),)-318.7(t)-5.5(hus)]TJ T* -.0198 Tc [(categorized)-401(as)-400.8(pan)-401(d)2.1(rug)-401(r)2.2(esistant.)]TJ 7.3823 0 0 6.5614 442.1479 587.0549 Tm -.0239 Tc (16)Tj 9.843 0 0 9.843 453.0896 582.6896 Tm -.0215 Tc [(The)-403.9(i).3(s)-5.1(o).4(l)-5.4(a)-.7(te)-403.9(re)-6.5(main)-5.3(ed)-402.7(in-)]TJ -14.4511 -1.1116 TD [(ter)-5.4(m)-.9(ed)-5.4(iat)-5.5(e)-.8(ly)-276.1(su)-5.4(sc)-6.6(ept)-5.5(i).2(bl)-5.6(e)-271.5(t).2(o)-276.1(m)-.9(i)-5.5(noc)-6.6(ycl)-5.6(i).2(ne)-277.3(\()-86(M)-.6(IC)-6.4(:)-270.5(8)-166.7(m)-6.6(g).3(/L)-6.6(\),)-272.7(wh)-5.4(ich)]TJ 0 -1.1174 TD [(is)-437(no)-5.2(t)-437.3(a)-.6(t)-437.3(m)-.7(ar)-5.2(ket)-437.3(i)-5.4(n)-437.2(C)-.5(ro)-5.2(ati)-5.3(a)-.6(,)-433.8(a)-6.4(nd)-437.2(ti)-5.3(gec)-6.4(y).5(cl)-5.4(ine)-438.4(\()-85.8(MI)-5.2(C:)-437.3(2)-166.5(m)-.7(g)-5.2(/).4(L\))-5.2(,)]TJ 0 -1.1116 TD -.0204 Tc [(which)-384.4(i)1.4(s)-378.4(r)-4.2(ece)-5.4(ntly)-378.6(present)-384.5(a).4(t)-384.5(t)1.4(he)-385.5(market)-384.5(in)-378.6(C)-5.2(r)1.6(oa)-5.4(tia)-385.5(and)-378.6(i)1.4(s)-384.2(ac-)]TJ T* -.02 Tc [(cepted)-430(a).8(s)-429.8(p)-3.8(art)-430.2(o)1.9(f)-430(t)1.8(he)-425.4(c)-5(o)1.9(mbine)-5(d)-424.3(trea)-5(tme)-5(n)1.9(t)-430.2(o)1.9(f)-430(M)1(DR)]TJ /F4 1 Tf 21.0229 0 TD -.0215 Tc [(Ac)-6.5(ine)-6.5(t).3(o-)]TJ -21.0229 -1.1174 TD -.0217 Tc [(bac)-6.7(ter)]TJ /F5 1 Tf 3.0066 0 TD -.0197 Tc [(infections.)-564.5(E)-4.7(nvironmental)-568.1(i)-3.6(solate)-563.4(E)-4.7(F)2.4(7)-568(s)2.4(howe)-4.7(d)-562.2(v)-3.5(ery)]TJ -3.0066 -1.1116 TD -.0217 Tc [(si)-5.6(mil)-5.7(a)-.9(r)-345.3(a)-.9(nt)-5.6(ibi)-5.6(o).2(t)-5.7(i).1(c)-346.5(r).3(es)-5.3(is)-5.3(tan)-5.5(c)-.9(e)-346.5(p).2(ro)-5.5(l)-5.6(e)-340.7(t)-5.6(o)-339.6(p)-5.5(an)-345.3(dr)-5.5(ug-)-5.5(re)-6.7(sis)-5.3(t).1(an)-5.5(t)-345.5(c)-.9(li)-5.7(ni-)]TJ T* -.0195 Tc [(cal)-423.9(isolate)-424.9(o)2.4(f)]TJ /F4 1 Tf 5.6675 0 TD -.0214 Tc [(A.)-428(ba)-5.2(uma)-5.2(n).5(n)-5.2(i).4(i)]TJ /F5 1 Tf 5.777 0 TD [(re)-6.5(cov)-5.3(e)-.7(re)-6.5(d)-425.8(i).3(n)-425.8(2)-5.3(013)-425.8(i)-5.5(n)-425.8(Ger)-5.3(m)-.8(an)-5.3(y)]TJ 7.3823 0 0 6.5614 546.2361 510.3495 Tm 0 Tc (5)Tj 9.843 0 0 9.843 310.8472 494.9857 Tm -.0215 Tc [(wit)-5.4(h)-489.1(th)-5.3(e)-490.3(e)-.7(xc)-6.5(ept)-5.5(i).3(on)-489.1(o)-5.3(f)-489.1(ti)-5.4(gec)-6.5(y).4(cl)-5.4(ine)-490.3(r)-5.3(es)-5.1(ist)-5.5(a)-.7(nc)-6.5(e)-490.3(i).3(n)-489.1(t)-5.4(he)-490.3(Ge)-6.5(rman)]TJ 0 -1.1116 TD -.0202 Tc [(isola)-5.2(t)1.6(e.)-328.9(The)-327.7(l)1.6(evels)-320.6(o)-4(f)-320.8(a)-5.2(ntibioti)]TJ 11.7095 0 TD -.0181 Tc [(c)-319.9(r)-1.9(es)4(is)4(tan)3.8(c)-3.1(e)-319.9(o)-1.9(f)-318.7(i)-2(s)4(o)3.8(late)-319.9(EF7)-318.7(w)-2.8(ere)]TJ -11.7095 -1.1116 TD -.0199 Tc [(com)-4.9(p)2(arable)-304.4(with)-303.2(those)-304.4(o)2(f)-303.2(t)-3.9(he)-304.4(clinical)-303.4(isolate)-4.9(s)-303(of)]TJ /F4 1 Tf 19.0416 0 TD -.0215 Tc [(A.)-307.2(bau)-5.3(man)-5.3(n).4(ii)]TJ /F5 1 Tf -19.0416 -1.1174 TD -.0212 Tc [(in)-327.6(Cr)-5(oat)-5.2(i).6(a,)]TJ 7.3823 0 0 6.5614 351.3259 466.5258 Tm -.0248 Tc (7,17)Tj 9.843 0 0 9.843 366.6896 462.1038 Tm -.0215 Tc [(w)-6.2(ith)-327.9(ex)-5.3(cep)-5.3(ti)-5.5(on)-327.9(tha)-6.5(t)-328(no)-327.9(cli)-5.5(n)]TJ 10.5518 0 TD -.0196 Tc [(ical)-326.1(isolate)-4.6(s)-320(resistant)]TJ -16.2251 -1.1116 TD -.0215 Tc [(bot)-5.4(h)-627.4(t).3(o)-627.4(a)-.7(mp)-5.3(ici)-5.4(lli)-5.4(n/s)-5.1(u).4(l)-5.4(b).4(ac)-6.5(tam)-628.6(a)-.7(nd)-627.4(co)-5.3(li)-5.4(sti)-5.4(n)-621.6(w)-6.2(e)-.7(r)-5.3(e)-622.8(r)-5.3(e)-.7(gi)-5.4(ste)-6.5(r).5(ed)-5.3(.)]TJ T* -.0202 Tc [(Ampicillin/sulbac)-5.2(tam)-327.8(a).6(nd)-326.6(co)]TJ 11.2545 0 TD -.0199 Tc [(listin)-320.5(w)-4.6(ere)-327.4(u)2(sed)-320.5(i)-3.8(n)-320.5(r)-3.7(ecommended)]TJ -11.2545 -1.1116 TD -.0216 Tc [(the)-6.6(r).4(a)-6.6(p).3(y)-472(i).2(n)-471.9(Z)-6.6(agr)-5.4(e)-.8(b)-5.4(s)-471.8(h).3(o)-5.4(s).5(p)-5.4(ita)-6.6(ls)-471.8(in)-477.7(rec)-6.6(e)-.8(nt)-472.1(y)-5.4(ear)-5.4(s,)-474.3(in)-5.4(clu)-5.4(d).3(in)-5.4(g)-471.9(t).2(h)-5.4(e)]TJ 0 -1.1174 TD [(per)-5.4(i).2(o)-5.4(d)-287.6(o)-5.4(f)-293.4(was)-5.2(t).2(e)-6.6(w)-.5(at)-5.6(er)-293.4(sa)-6.6(mpli)-5.6(ng)-5.4(.)-290(I).4(t)-293.5(i)-5.5(s)-293.2(pos)-5.2(si)-5.5(ble)-294.6(t)-5.5(hat)-293.5(t)-5.6(he)-294.6(pan)-293.4(d)-5.4(rug)]TJ 0 -1.1116 TD [(res)-5.1(i).3(s)-5.1(t).3(an)-5.3(ce)-547.9(was)-546.5(d).4(e)-6.5(v).4(el)-5.4(ope)-6.5(d)-541(i)-5.4(n)-541(h)-5.3(osp)-5.3(i).3(t)-5.5(a)-.7(l)-541.1(a)-6.5(nd)-546.7(is)-5.1(ola)-6.5(t).3(e)-542.1(E)-6.5(F7)-546.7(was)]TJ T* -.0182 Tc [(d)3.7(i)3.6(schar)3.8(g)-2(ed)-330.3(in)3.7(t)3.6(o)-330.3(sewag)3.7(e)-331.5(sy)3.7(st)3.6(em.)]TJ 1.0137 -1.1174 TD 0 Tc [(Multiplex)-260.2(PCR)-264.4(and)-263.6(sequencing)-267.9(conrmed)-265.6(the)-263.8(presence)-272.4(of)]TJ -1.0137 -1.1116 TD [(both)-240.7(intrinsic)-241.8(chromosomally)-243.8(located)]TJ /F4 1 Tf 15.1768 0 TD (bla)Tj /F5 1 Tf 7.3823 0 0 6.5614 472.8755 372.8125 Tm (OXA-51-like)Tj 9.843 0 0 9.843 514.6581 374.4566 Tm [(gene)-242.9(and)]TJ -20.7061 -1.1116 TD [(acquired)-386.8(plasmid-located)]TJ /F4 1 Tf 10.6439 0 TD (bla)Tj /F5 1 Tf 7.3823 0 0 6.5614 428.2015 361.8708 Tm [(OXA-23-)-12.1(like)]TJ 9.843 0 0 9.843 471.4581 363.5149 Tm [(gene.)-384.5(Sequences)-388.6(of)]TJ /F4 1 Tf -16.3172 -1.1174 TD (bla)Tj /F5 1 Tf 7.3823 0 0 6.5614 323.433 350.8723 Tm [(OXA)-11.6(-51-like)]TJ 9.843 0 0 9.843 367.9369 352.5164 Tm [(\(KX468062\))-519.6(and)]TJ /F4 1 Tf 7.5798 0 TD (bla)Tj /F5 1 Tf 7.3823 0 0 6.5614 455.1873 350.8723 Tm [(OXA-23-)-12.1(like)]TJ 9.843 0 0 9.843 499.6912 352.5164 Tm (\(KX468063\))Tj -19.1856 -1.1116 TD [(genes)-399.3(showed)-400.1(100%)-402.9(identity)-396.4(with)-403(sequences)-400.1(from)-403(clinical)]TJ T* [(isolates)-425.8(available)-435.4(in)-422.8(GenBank)-426.6(\(Fig.)-428.2(1\),)-426.1(which)-428.1(suggest)-429.1(the)]TJ T* [(potential)-456.3(origin)-461.8(of)-457.2(isolate)-459.5(EF7)-453.6(in)-457.3(hospitalize)-10.2(d)-456.1(patients)-460.6(or)]TJ 0 -1.1174 TD [(hospital)-482.5(wastewaters.)]TJ 7.3823 0 0 6.5614 397.4739 313.0582 Tm (18)Tj 9.843 0 0 9.843 409.6062 308.6928 Tm [(Untreated)-486.8(hospital)-482.5(wastewaters)-490.7(in)]TJ -10.0334 -1.1116 TD [(Zagreb)-269.3(are)-270.5(directly)-270.7(discharged)-273.6(into)-269.6(sewage)-270(system,)-271.4(which)-272.6(is)]TJ T* [(collected)-608.2(and)-609.2(treated)-610.4(at)-602.5(investigated)-610.3(central)-610.4(wastewater)]TJ 0 -1.1174 TD [(treatment)-412.4(plant.)-413.5(Removal)-409.9(of)-411.1(carbapenem-resistant)-423(bacteria)]TJ 0 -1.1116 TD (and)Tj /F4 1 Tf 1.918 0 TD [(A.)-472.3(baumannii)]TJ /F5 1 Tf 6.0938 0 TD [(in)-474.6(the)-471.1(secondary)-479.7(wastewater)-478.2(treatment)]TJ -8.0117 -1.1116 TD [(plant)-243.1(is)-238.3(moderate.)]TJ 7.3823 0 0 6.5614 381.203 258.2928 Tm (10)Tj 9.843 0 0 9.843 391.0109 253.9275 Tm [(Thus,)-239.2(certain)-247.6(number)-245.1(of)]TJ /F4 1 Tf 9.8491 0 TD [(A.)-241.9(baumannii)]TJ /F5 1 Tf 5.633 0 TD (is)Tj -23.6263 -1.1174 TD [(released)-502.9(through)-503.1(the)-499.9(efuent)-499.6(wastewater)-507(into)-500(the)-505.7(natural)]TJ 0 -1.1116 TD [(recipient)-440(Sava)-438.5(River.)-437.5(In)-439.9(aquatic)-443.4(environmental)-439.9(conditions)]TJ T* (MDR)Tj /F4 1 Tf 2.517 0 TD [(A.)-241.9(baumannii)]TJ /F5 1 Tf 5.633 0 TD [(has)-246.2(the)-246.5(potential)-248.9(to)-244.2(multiply)-246.7(and)-246.4(survive)]TJ -8.15 -1.1174 TD [(up)-474.5(to)-480.4(50)-474.5(days.)]TJ 7.3823 0 0 6.5614 372.8125 214.4692 Tm (10)Tj 9.843 0 0 9.843 384.8881 210.0472 Tm [(Therefore,)-484.5(the)-476.9(viable)-481.5(pan)-476.8(drug-resistant)]TJ /F4 1 Tf -7.5222 -1.1116 TD [(A.)-357.1(baumannii)]TJ /F5 1 Tf 5.8576 0 TD [(recovered)-360.1(from)-356.9(efuent)-355.6(wastewater)-363(could)-358.1(be)]TJ -5.8576 -1.1116 TD [(easily)-383.4(spread)-383.1(through)-376.4(the)-384.7(natural)-384.6(water)-383.2(body,)-376.5(which)-382(could)]TJ T* [(represent)-710.2(an)-700.3(environmen)-8.9(tal)-701.6(reservoir)-709(of)-704.9(this)-707.2(emerging)]TJ ET 59.754 699.534 239.131 .28345 re f 59.754 527.584 239.131 .22681 re f 59.754 680.882 239.131 .22681 re f BT /F9 1 Tf 9.845 0 0 9.845 81.3543 725.1588 Tm (Table)Tj /F5 1 Tf 3.0002 0 TD (1.)Tj /F9 1 Tf 1.2496 0 TD [(MIC)-333(Values)-335.8(of)-331.2(Tested)-335(Antibiotics)]TJ -1.6239 -1.0135 TD [(Against)-331(Environmental)-340.7(Isolate)]TJ .7947 -1.0135 TD (of)Tj /F11 1 Tf 1.336 0 TD [(Acinetobacter)-331.4(baumannii)]TJ /F4 1 Tf -6.9506 -1.8427 TD [(Antimicrobial)-339.2(category)-5079(Antibiotic)-946(MIC)-333.2(\(mg/L\))]TJ /F5 1 Tf 0 -1.8946 TD [(Carbapenems)-9835.9(MEM)]TJ /F10 1 Tf 20.9035 0 TD (>)Tj /F5 1 Tf .5528 0 TD (16)Tj 7.3837 0 0 6.5625 280.7999 672.7747 Tm (a)Tj 9.845 0 0 9.845 210.274 658.4313 Tm (IMI)Tj /F10 1 Tf 5.6146 0 TD (>)Tj /F5 1 Tf .5528 0 TD (16)Tj 7.3837 0 0 6.5625 280.7999 662.7966 Tm (a)Tj 9.845 0 0 9.845 59.7543 645.5054 Tm [(Fluoroquinolones)-8228.9(CIP)]TJ /F10 1 Tf 21.1511 0 TD (>)Tj /F5 1 Tf .5528 0 TD (4)Tj 7.3837 0 0 6.5625 278.3621 649.8707 Tm (a)Tj 9.845 0 0 9.845 210.274 635.5274 Tm (LVX)Tj /F10 1 Tf 5.8622 0 TD (>)Tj /F5 1 Tf .5528 0 TD (8)Tj 7.3837 0 0 6.5625 278.3621 639.8928 Tm (a)Tj 9.845 0 0 9.845 59.7543 622.6014 Tm [(Aminoglycosides)-8282.9(TOB)]TJ /F10 1 Tf 20.9035 0 TD (>)Tj /F5 1 Tf .5528 0 TD (16)Tj 7.3837 0 0 6.5625 280.7999 626.9668 Tm (a)Tj 9.845 0 0 9.845 210.274 612.6235 Tm (GEN)Tj /F10 1 Tf 5.6146 0 TD (>)Tj /F5 1 Tf .5528 0 TD (16)Tj 7.3837 0 0 6.5625 280.7999 616.9888 Tm (a)Tj 9.845 0 0 9.845 210.274 602.6455 Tm (AMK)Tj /F10 1 Tf 5.6146 0 TD (>)Tj /F5 1 Tf .5528 0 TD (64)Tj 7.3837 0 0 6.5625 280.7999 607.0109 Tm (a)Tj 9.845 0 0 9.845 59.7543 589.7195 Tm [(Tetracyclines)-9878.9(MIN)-4185.3(8)]TJ 7.3837 0 0 6.5625 275.4708 594.0849 Tm (b)Tj 9.845 0 0 9.845 210.274 579.7416 Tm [(TGC)-4123.3(2)]TJ 7.3837 0 0 6.5625 275.4708 584.1069 Tm (b)Tj 9.845 0 0 9.845 59.7543 566.8156 Tm (Penicillins/)Tj /F6 1 Tf 4.5205 0 TD (b)Tj /F5 1 Tf .5528 0 TD [(-lactamase)-339.6(inhibitors)-1738(SAM)]TJ /F10 1 Tf 15.8302 0 TD (>)Tj /F5 1 Tf .5528 0 TD (32)Tj 7.3837 0 0 6.5625 280.7999 571.181 Tm (a)Tj 9.845 0 0 9.845 210.274 556.8376 Tm (TIM)Tj /F10 1 Tf 5.3612 0 TD (>)Tj /F5 1 Tf .5528 0 TD (128)Tj 7.3837 0 0 6.5625 283.2944 561.203 Tm (a)Tj 9.845 0 0 9.845 59.7543 543.855 Tm [(Folate)-336.7(pathway)-338.5(inhibitors)-4870.6(SXT)]TJ /F10 1 Tf 20.6501 0 TD (>)Tj /F5 1 Tf .5528 0 TD (320)Tj 7.3837 0 0 6.5625 283.2944 548.277 Tm (a)Tj 9.845 0 0 9.845 59.7543 533.9337 Tm [(Polymyxins)-10508.9(CST)]TJ /F10 1 Tf 20.9035 0 TD (>)Tj /F5 1 Tf .5528 0 TD (16)Tj 7.3837 0 0 6.5625 280.7999 538.2991 Tm (a)Tj 6.5633 0 0 5.8334 67.748 519.6471 Tm (a)Tj 8.7511 0 0 8.7511 70.696 515.792 Tm (Resistant.)Tj 6.5633 0 0 5.8334 67.748 510.6896 Tm (b)Tj 8.7511 0 0 8.7511 71.0362 506.8345 Tm [(Intermediate)-331.5(according)-333.7(to)-333.3(EUCAST)-335.4(and)-334.6(CLSI)-335.7(criteria.)]TJ -.3757 -1.0301 TD [(AMK,)-337.8(amikacin;)-343.1(CIP,)-330.4(cipro)-10.7(oxacin;)-335(CST)-7.9(,)-333.1(colistin;)-339.1(GEN,)-336.7(genta-)]TJ -.9134 -1.0236 TD [(micin)-9.8(;)-179(IMI,)-187.9(imipen)-8.7(em;)-181.9(LVX,)-187.7(levo)-8.2(oxacin;)-191.2(MEM,)-184.1(meropenem;)-191.6(MIC,)]TJ T* [(minimum)-338.3(inhibitor)-8.9(y)-329.2(conce)-10.7(ntration;)-334(MIN,)-334.1(minocy)-9.9(cline;;)-339(SAM,)-335.4(am-)]TJ T* [(picill)-8.6(in/sulbac)-12.4(tam;)-820.8(SXT,)-826.6(trimethop)-8.9(rim/sulfamet)-12.8(hoxazole;)-826.2(TGC,)]TJ T* [(tigecyc)-12.3(line;)-250.7(TIM)-7.9(,)-248.8(ticarcill)-11.2(in/clavula)-12.7(nic)-249.1(acid;)-259.6(TOB,)-252.7(tobramycin)-10.2(.)]TJ ET q 336.132 0 0 106.583 61.795 57.373 cm /Im1 Do Q BT /F7 1 Tf 9.845 0 0 9.845 408.6991 152.2204 Tm [(FIG.)-233.1(1.)]TJ /F5 1 Tf 4.0137 0 TD [(Unrooted)-154(phylogentic)-152(tree)]TJ -4.0137 -1.0135 TD [(\(NJ)-239.7(method,)-242.2(number)-244.4(of)-238.1(differences\))]TJ T* [(constructed)-256.4(on)-249.6(the)-251.9(basis)-247.8(of)]TJ /F4 1 Tf 10.9355 0 TD (bla)Tj /F5 1 Tf 7.3837 0 0 6.5625 529.0015 130.6204 Tm (OXA)Tj 9.845 0 0 9.845 408.6991 122.3433 Tm [(genes)-254.7(encoding)-252.3(OXA-type)-253.6(carba-)]TJ 0 -1.0135 TD [(penemases.)-253.9(GenBank)-252.9(accession)]TJ T* [(numbers)-251(are)-252.9(given)-253.9(next)-247.2(to)-249.8(the)-251.9(name)]TJ T* [(of)-249.6(each)-255.1(strain.)-252.5(Gene)-249(sequences)-255.1(of)]TJ /F4 1 Tf 0 -1.0077 TD (bla)Tj /F5 1 Tf 7.3837 0 0 6.5625 421.3416 80.8441 Tm (OXA-51)Tj 9.845 0 0 9.845 449.5747 82.4882 Tm [(type)-252.9(are)-252.9(marked)-251.3(with)-252.8(a)]TJ /F4 1 Tf -4.1519 -1.0135 TD [(black)-203.3(dot)]TJ /F5 1 Tf 3.8582 0 TD [(and)-199.9(of)]TJ /F4 1 Tf 2.6777 0 TD (bla)Tj /F5 1 Tf 7.3837 0 0 6.5625 485.6313 70.8661 Tm [(OXA)-11.2(-23)]TJ 9.845 0 0 9.845 513.4109 72.5102 Tm [(type)-201.1(with)]TJ -10.636 -1.0135 TD (a)Tj /F4 1 Tf .6968 0 TD [(black)-255.1(triangle)]TJ /F5 1 Tf 5.6031 0 TD (.)Tj /F8 1 Tf 8.9663 0 0 8.9663 59.7543 749.7069 Tm [(PAN)-338.6(DRUG-RESISTANT)-340.4(ENVIRONMENTAL)]TJ /F12 1 Tf 20.7581 0 TD [(A.)-332.3(BAUMANNII)]TJ /F8 1 Tf 32.2532 0 TD (495)Tj ET endstream endobj 23 0 obj <>stream AdobedC        s!1AQa"q2B#R3b$r%C4Scs5D'6Tdt& EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz?Nlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lW-4*TbIsp9H];.Co̝fGmW:fj)qH̱-qohj»0"ky VNm]wݚFFI84Ν:Ci5k}STգJ:Y:`WB?2ϡ>[Mv\EsklnȈpLrWtzBu*c;ѡ/4frx;S"޲ii%Dre3!PN S"v4ky"U"@ц侗 IaF%r$P^K[q+JҠHJ ?^hՒhjLJŬ,|䄊~lVzͼ.>me_]D5ݙZPܚ 6<.{4j|cfחZbȏ"^F/P|Jo No2h7uTkxG. t8RF:_ͻH-D]QtK #99+_bh{ӼoayJzVfUYX܊ Us0GಿGI,:&9r#+3M"ceڣ4Σ6e!фI d ]CǾZ6_zI,41s{;oglr6 Qaom糏QmA%xx~в7/ 'gM?z&/12Ish:2}6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٲg̺Gok o3Cu41E(JT9k Njq2i7btѢʅݚܛnCKʞdS&5+4y/'OkeXce{sR~p|/H!60IX[[Ռ^/8m(R#.vmZߒeΩmho!k?4lL%T|@ V?'T:k9@C@Z17tY^بFW$^{dM;PzfoOAg\Y WԯdcU򯘵5t/}NMYA&5G%HڰS%y>ܶ'yyʾOƟ ^JB.II񙝦*+Si,t'wx^h5ݺOc[yVaP6F!'?O0hߣ[Ŀ}E{kKYR:|!gJݠyDSA&,Igۺ[ᔳ>sMGonm Mm\DW2۝<0e?.I}sZ7w6k/cṫȒGDq pWY8_h)g"Vy6MYdhz e ,PGN~gX^{ ,-44E t]fƮ}Uw2JƼx6B<CȿWd6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6leU,Ɗ ~ny6dg8H2=)80,yJçl/{[Y1@t?JJRa Nw?PlmfK+ky5G%e>gĶFeGPNdX0\iy EԟLԵx࿎4Kq2S\ sXiMn {e^6뒭+Tm6Sӧ[ kkUi+6׵@n5}f,P 2׊`N`,>gu8oۅV6 .w-'Vu}: KLK os:֕S8]4{i8Jd n1-rJl9,d!]Wylbɐ]WrzeZyɷ`˶ŴEܣ,>҃U1?uZ]#Jmo5XFh3dvnӾHsf͛!iɡ_ǫɈo6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛#xEߗ4{+^^XZ4LRԴ_'Iv__&$. dه?6+(]?MV8m{_ϗZR1GSsGVѴFt˲hj:ϨIg} )ϩtmcbθߗ}B:ӽVE$Kxn#<n 4J EcߢtK-OB }zY׷J+ rg#mޙм ^iO6cW>h=ԵVdO;Ck3cB xi|Qc80:P;g#Ҭk#w g|V{ [puI7m& R>,~qNgm{oNn 4[UCV[5~9m\y^c[*LK{imR(%bis+e`S`Z|5mq'ɗJs smN@#-w*vڕ0 O!2MqF\*p)ʕ + ˱O y9;f)5)fw|a \yHV.IkyZH I,Z)uЎM,7 v*7yFӴ/y\4_^Lbh_@7G˂P^ћ6lOM"=_LE|ٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l x|QKLٲ9(j?P*.Ytkmʵq_zM&+6K,ZIfbjI%*I8l8Q$UcE$ 9x$k,S=9n5i!-mP=]׊IQ(8Z ok$!QZ(Z7llR+kX#XP{P[@[DAqFGUlX#!Mvw,P^-3MV[HmX#HV@*(=JAlX=__OW?S)ϟ˭w6{ pK}nF0zr9/s66Y@ڊ/1!/)Ξ]/L[V:zox#A1A&Jr#ڸ@6\OJORD8;ӓ/~S]Yh61w<6"PePFk6lOM"=_LE)蚔}qf%񳵞;`Ž~;w1vϨ[$x%31$T-Ğ5^T&g7Vw3\\>dD,ht?1h\s׋VSըË)sMgZ俙ϕoFAwk]IxC$֌Ho8hzוೊʹmSSݜܖIR<*?'%>FUb?7O24h1n@o{x`)cռ2%EhC4ҙ D7)+aǘ?2|Ri&km'0#P#|$rFs!A~?}=C/SNѭ_}gDм,H\Z,K:fcSXt$^q򶫨J XvnEMXmzk:muc1^JS9[ŷGGP7&^u~'ca=}9uMƍk4nlDt#EA(PW_e ;۸|kfiИ;XtɿAO3зW7ϗ½rZWT:˨IpZ]ܕBʌ)@QS/R||-7 Կ7_ M/'+?}pK/R||-7 Կ7_ M/'+?}pK/R||-7 Կ7_ M/'+?}pK/R||-7 Կ7_ M/'+?}pK/R||-7 Կ7_ M/'+?}pK/R||-7 Կ7_ M/'+?{pK/R||-7 Կ7_ M/'+?}pK/R||-7 Կ7_ M/'+?{pK/R||-7 Կ7_ M/'+?{pK/R||-7 Կ7_ M/'+?}pK/R||-7 Կ7_ M/'+?}pK/R||-7 Կ#~t\ٮ^:7ERy<1k6l俗W5v-nxG_Nw:XI?rZo>o\A_O\w--ē p](8DǙ|߭YCyymIby M©-⥘a(SPOL?|ahv{WcD?WSu3vP_>VԿ6l42[?oz `2\꿗M״BH^i Rdfy8G䞙8h?)44R1IA# 6c-pHd=xhT޻7Xe:ZlTl>tַ,@}Yo5?&kڵǚau,u!s5}f‡<| ԮL|iO>QdoX(ۡFVhkkyU[M ^Iɦlٳf͐szΧw}sԌmRi|b!WT) t_0]kУ X,v[3jwcj _;1a D~ȣ~67omtڅ2ےxIə`M@o&e޴z|m?P`v^ʛ`v# )jl[IuVeqLȕ^lvR@ X0 ާk.htn力y,KHƇ8M]CN6Y$wC4rySY#wH/<۟/|[}_Id16R,h|p_[ohWss1xFG]EٲEz&f͛6lٳdGoc_z'f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛!_")ri6lٳf͛6lٳf͛6lٳf͛6ly&&"ɾlٳf͛6lqWlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfWĐRvRVmO!VmO!VmO!Bǭg7t++/,S\[ͮkJiG$IÏ:y>[ˊ[&ASa&=n `?0)hz͗4X=g[V22$q,կ@)`\zK+5;daokg7rFm-ଢ଼OT׬4_.Ϯj6VVY4Q'Dz(F[NɵK[fxDR938l_umSH+AuaSmj&hs&cc]'tFnf_Qn0I 7- t;d[K9&Ou˽ݤFK{h2IdR+~)w86k6^ao^y>ńs%͔ubtW!m{9FSwksu\بKg Q QaڴHɾe%cũǤqtVrE |O?mjW͐4/cY7͛6lٳf͛ ?N?3Jy8͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l[4]vfB]Id5SŶ=2;*sM3N~Uԩ47ʿ4Ff9WRHL?*T??T_Jg#G0A|x׺&g]{hV7(H%j@&5o3kl "MxCX~&܏$SOfNCheimb\{kVz74=RӦt+uk7TK. )hЊ {l(?Ϳ~mo/;j6osMy x"?Vhʫ٫ray KKYfKOG?6T#u97'U|`坌fqik$qD.?J$?侣e-W& [iv"I9ėv-/&ckiyW:r\0.Z5Hj939 jY'^o[ +MJXljwV(\b w+*:^jZ'KqoDmgxxrc$ @UQEQv/'iv &Ak 0?1ΛdE՟50Y"齚J~28W?$yUlu{(V+w8@\<>CF[n\-.y<&,Z{af)'h5-(j7Mz͵hT׭xn iomF]R槉?)4[=V%kױ_O2z~JF#,M0N{-fytG^򌺌z-13Y(qƲ 95=BZ׭|j[7u'h3Ao$ S"ns-_[k3{Aنn.Hcey9 kƻ5k=MVix(-閥i:flٳf͛6lqWlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lJ/J犠ruhFHmemlZSԊ$FUٳf͛6lٲ7=wٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͐˿%k*Oz lָ}4ߊ,Z>e.l8# e4:DmJI_/7ܲi/46WM>oܙgbO'>7-t։>^=͔EgX۲M,gGVNojߚ֑Xy[PN]_W{&X= #bcRkq7Pt]Bؓmy w[jCC&0H eIʑ,PT^iKw[ק[Ȭd4ԺPtٳf͛6lٲ7=wٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳfȝΩ;!.4з7B$nacW~;4zw7M"+ۊ‹H)V/1\_/"mVyF@;d|c-2yRW{yg٧奸&MĒRA1o˿.xJf}_C7^lX۩*esmeW$>-'9 Mu{M5F?R_CI 2`:Uwĭ/44,^Mt5-rxRY%n0DO?^sҮ,_W[u;H{5xksON߰0kt]PV|okZ0= 67>O5Ӯ5_-^"=SP򅬉(4~ *|*f0'w0~^nt0lQ-^ll[>7qUdr4' ,+k[S_iwZW{4r7G^b}^O'  Īe2ǐÍ[u2 SI#UjB{WX^$Id=Bxk{WjQnn"GSm[c:N6yۤrO67d#fxc@d<0V};Gn?F{o\Ɍiw`v4{+W.aa_%k c7U> ?mo+ȺY \-(ksJNLaEE3\44][jzd~c.Y>4\J,yu@yApߛPЬC/j- *b~Zy jHRQ|m#sy>FD'ע|!to-kvڷfJ=Pm[GvէWXGԯAϔ[idt2U+we4n-cQ(?'0W׏(7~MGDƥ$q5[qB ^D1+k˳yQ/4zN]C&+mfb#}3-Cе eik5W'cN;%$Α6lٳd'%o¿il[~RoZwO~uYMBekU"n+rȜpy/2izÝ/^x/^+.>'բ1D乻Id_`ƪޭOewq\Rmm<W-0<( Vi$uG夺< ͺn'.[5H G%;9U4Zt^&&{,Nq48Y8Ps$.gG&y<(In݌LጙI$Nc6>e0F_ZfWk Xi#NyV>Q_93f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l~j^\α{9Lmx/(B¿8y͐뚭=4q\5ڹ Dz4s}a]O._VAZЛF13OsikJ\t2b "c߈ Vniԟ >NPsV;zihUHc[n%=P#z RߨSW~ NLk_fҁ~QL|GAœi$hUQ@KtiHcyR#’"HcL)6cC˚7U)2!k4oyr7ig/Xi78v6jcdQKдc_vH衣Csl,i,,yX,mV?k;˫Gp&6p\ٖ+o[p%I{_\YZ{qs rCEv [;Gtc^n$UEtK#*fc'e!?{}7E4-Tд]L=kW,$y :Zai6lٳd'%oɶlٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6l뿕Ni5;y[ xm?݋#un=>1c2W̺tK{kEq 8.wpRQ'{ T,Bā \GY򖉫Z_^DZYcv"쑹QA$z$1zzlV8THU=0=P;a-KO,]TrL:мZn-CbKK31,jNFt_,h.d:Gt$ = gjakWv>T3hh1q$F,5Wʟ%ڹ BKs8{!ZLj][~Uy2[]Z+iGr5cےZ;BY^|nO?UQMga-0a$Z1nM)oNB ̖j=٬:C+Bm Ot;Q&x-wm12 ~#8r$;HʿZ̷Zr\Ky$Kl.nf--yD~+6lٱbIDm)Kq⠐*{oߙVL"K-R%>]f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳ`=+XukSw\-ͺ,DHbw3f́5M_MҠPmhv Mݝyf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳ[还Z Gյ_J]0\PEʧN__+ey:7o_[//cFMyR$L^4;빳f͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٳf͛6lٲUEh6rsH|h>stream hLMhQgCQRf6$O0icjmmBXJ&&d-JB7$OZ?h=y B USD'2ނa~Hyr-hs7ӉsJ= ݒ: o~T:E >IʙRlܛqX2IbTZٜi3,Wac;e]-+gL1Mmn9]ut1T3 :8(,>> p."ԡ{R__\>ӄ@萌} 2  崕'|ōuAѧ2Qē/"V}ޅ/nTӟmpKΨVI)y~ʴ,c#C1[,gtm SMQ*^m­^Yn 8-Q>stream hl}LSWo+D (Z6p UZB)Ka"m):9㜺4fI'qS333gNf˜}}H)%H榯]HXuLZNݮ5CX3搷[Oj4H9J$iZnGO,^/U.ON e U>UcخU&Vo3+ JQmj|jy9ziMZER&^gռ٨hjco(* J-+4 F^'r&F6괦E؄zVK56J(Zt"RjL2OR%*!J/N{q}ک̧O=EY &w]7=& 6cwY=s ]MvyIΖɊ@. $È |W]eo.e]v[p4K@NLWmz';. ̂aRhqQYsw*Fr~3-hוQwҏHxl4+w$1'ÅY6.ݚkdF:?Lc0KYͭ'0)nhYɒ@9$X쩫ߎqnTP`I"~ܣA{}paZ(LVe(_a!g@ Ƈ¥&QYRx _+6\6>4/,*g o9ɤQd崸2Ѥv_n ~x\81d LF DŽԆ{OiS{hpWb$7CDVO77:ޓN~ " V1LJA"$yFDoH=F$V 4vɽKgwN2v2pG$%q$>$h9( ı8`Y1İ$1<9bXqhڪ݅d}Ja~>sx `h]]wKC+/`Ie8kU5܃/C#Pj.۞a+0 u,[cU(=x݃y<\C)D#?~:ŞVPt'\uuĆ cِs w6'z&z.65 &1OyɄftgAg`;@F endstream endobj 40 0 obj <>stream /GS1 gs BT /F5 1 Tf 9.843 0 0 9.843 62.022 725.1588 Tm 0 0 0 rg 0 Tc 0 Tw [(pathogen.)-464(M)15.3(o)21.9(r)16.2(e)15(o)16.2(v)21.9(e)15(r)16.2(,)-360.5(s)16.4(i)21.8(n)16.2(c)15(e)-359.4(t)16.1(h)21.9(e)-365.1(p)21.9(l)16.1(a)15(s)16.4(m)20.7(i)16.1(d)16.2(-)22(l)16.1(o)16.2(c)20.8(a)15(t)16.1(e)20.8(d)]TJ /F4 1 Tf 19.2374 0 TD -.0162 Tc [(bl)5.6(a)]TJ /F5 1 Tf 7.3823 0 0 6.5614 263.4519 723.5148 Tm -.0201 Tc [(OX)6.7(A-)5.7(23-)5.7(l)7.5(ike)]TJ 9.843 0 0 9.843 62.022 714.1605 Tm -.0164 Tc [(gene)-467.9(i)5.4(n)-466.8(iso)5.5(l)-.3(at)5.4(e)-467.9(E)-1.4(F)5.7(7)-466.8(may)-466.8(b)5.5(e)-467.9(s)0(elf-t)5.4(ran)5.5(s)0(fer)5.6(a)-1.4(bl)5.4(e,)]TJ 7.3823 0 0 6.5614 244.233 718.5825 Tm -.0162 Tc (19)Tj 9.843 0 0 9.843 255.9117 714.1605 Tm [(t)5.6(h)0(e)-467.7(e)4.6(fu)5.7(e)-1.2(nt)]TJ -19.6982 -1.1116 TD -.0171 Tc [(wastewater)-311.9(represent)4.7(s)-311.7(a)-307.3(potenti)4.7(al)]TJ 13.2473 0 TD -.0157 Tc [(e)5.1(p).5(id)6.2(emi)6.1(olo)6.2(g).5(ic)5.1(al)-310.7(r)6.3(e)-.7(ser)6.3(voi)6.1(r)-310.5(o).5(f)]TJ -13.2473 -1.1116 TD -.0171 Tc [(the)-532(c)-2.1(arbap)4.8(e)-2.1(nem)-537.8(r)-.9(esist)4.7(a)-2.1(nce)-537.7(g)-.9(ene.)-533.1(The)-537.7(i)4.7(mpact)-536.7(o)4.8(f)-536.5(s)-.7(econd)4.8(ary)]TJ T* -.0177 Tc [(treated)-174.3(m)-2.7(u)4.2(n)-1.5(icipal)-174.4(wastewaters)-174.1(o)]TJ 12.176 0 TD -.0167 Tc [(n)-167.5(t)-.6(he)-168.7(occurrence)-168.7(o)-.5(f)-173.3(c)4.1(ommuni)5.1(ty-)]TJ -12.176 -1.1174 TD -.0169 Tc [(acquir)5.1(e)-1.9(d)]TJ /F4 1 Tf 3.5998 0 TD -.0165 Tc [(A.)-284.9(b)5.4(aumanni)5.3(i)]TJ /F5 1 Tf 5.5236 0 TD [(i)5.3(nfecti)5.3(ons)-282.3(out)5.3(side)-283.7(th)5.4(e)-283.7(hosp)5.4(ital)-288.4(e)4.3(nvir)5.5(on-)]TJ -9.1234 -1.1116 TD [(ment)-248.1(sho)5.4(u)-.3(ld)-248(be)-249.1(f)5.5(urth)5.4(e)-1.5(r)-248(i)-.4(n)5.4(v)-.3(est)5.3(i)-.4(gated)5.4(.)]TJ /F8 1 Tf 8.9663 0 0 8.9663 62.022 637.455 Tm 0 Tc (Acknowledgments)Tj /F5 1 Tf 9.843 0 0 9.843 72 621.014 Tm [(Th)19.6(is)-462.9(wo)14.2(rk)-462.9(ha)19.7(s)-479(b)0(e)19.7(e)0(n)-464.1(s)0(u)15.3(p)0(p)20.8(o)0(r)20.9(t)0(e)19.6(d)-473.4(by)-468.7(th)20.7(e)-474.6(C)0(r)14.1(o)0(a)19.7(t)0(i)20.6(a)0(n)-464.1(S)0(c)14.1(i)0(e)19.6(n)0(c)19.7(e)]TJ -1.0137 -1.1116 TD [(Fo)21(un)20.8(da)13.9(ti)20.6(on)-532.1(\(P)21(ro)20.9(je)19.5(ct)-533.4(No)14.2(.)-539.1(I)0(P)21(-)0(2)15.1(0)0(1)20.8(4)0(-)20.9(0)0(9)20.8(-)0(5)20.9(6)0(5)15.1(6)0(\))20.9(.)-539.1(We)-535.5(th)20.7(an)19.7(k)-542.5(M)0(.)]TJ T* [(Ga)18.8(nj)20.7(to)15(,)-297.2(Z)0(a)18.5(g)0(r)20.9(e)0(b)-291.3(W)0(a)17.4(s)0(t)15.1(e)0(w)18.8(a)0(t)19.5(e)0(r)-291.3(M)0(a)18.8(n)0(a)19.7(g)0(e)19.7(m)0(e)18.4(n)0(t)-290.3(a)0(n)19.7(d)-300.6(Op)14.2(er)19.7(at)19.5(io)20.7(n)-300.6(L)0(t)19.5(d)0(.)]TJ 0 -1.1174 TD [(fo)20.9(r)-323.6(p)0(r)15.1(o)0(v)20.8(i)0(d)20.7(i)0(n)20.7(g)-323.6(th)20.7(e)-324.8(w)0(a)18.8(s)0(t)20.9(e)0(w)13.1(a)0(t)19.5(e)0(r)-314.4(s)0(a)19.9(m)0(p)19.6(l)0(e)-314.5(a)0(n)19.7(d)-323.6(S.)-315.4(Ka)18.8(za)18.5(zi)19.5(c,)-311(Ru)19.8(dj)14.9(er)]TJ 0 -1.1116 TD [(Bo)19.8(sk)21(ov)15.1(ic)-314.5(In)20.9(st)20.9(it)20.6(ut)15(e)-319(f)0(o)15.1(r)-323.6(MA)19.1(LD)18.8(I-)20.9(TO)18.8(F)-323.5(M)0(S)-314(i)0(d)20.7(e)0(n)19.7(t)0(i)14.8()0(c)19.8(a)0(t)19.5(i)0(o)20.7(n)0(.)]TJ /F8 1 Tf 8.9663 0 0 8.9663 62.022 555.3069 Tm [(Compliance)-337.5(with)-330.5(Ethical)-337.7(Standards)]TJ /F5 1 Tf 9.843 0 0 9.843 72 538.866 Tm [(This)-673.7(research)-681.3(fully)-673.9(complies)-680.6(with)-673.7(Ethical)-679.8(Standards)]TJ -1.0137 -1.1174 TD [(applicable)-517.2(for)-510.1(this)-517.1(journal)-510.2(and)-511.3(the)-517.2(relevant)-513.6(national)-512.6(and)]TJ 0 -1.1116 TD [(international)-404.3(ethics-related)-401.6(rules)-398.2(and)-401.9(professional)-401.3(codes)-399.3(of)]TJ T* (conduct.)Tj /F8 1 Tf 8.9663 0 0 8.9663 62.022 484.0439 Tm [(Disclosure)-336.7(Statement)]TJ /F5 1 Tf 9.843 0 0 9.843 72 467.603 Tm [(No)-331.4(competing)-336.3(nancial)-340.7(interests)-334.7(exist.)]TJ /F8 1 Tf 8.9663 0 0 8.9663 62.022 445.7196 Tm (References)Tj /F5 1 Tf 9.2951 0 0 9.2951 66.6708 429.6188 Tm [(1.)-500.4(Maragakis,)-361.8(L.L.,)-351.9(and)-358.4(T.M.)-355.3(Perl.)-357.2(2008.)]TJ /F4 1 Tf 17.4011 0 TD [(Acinetobacter)-359.6(bau-)]TJ -16.1508 -1.1223 TD (mannii)Tj /F5 1 Tf 2.7813 0 TD [(:)-402.1(epidemiology,)-398.4(antimicrobial)-403.9(resistance,)-402(and)-401.1(treat-)]TJ -2.7813 -1.1284 TD [(ment)-333.1(options.)-334.5(Clin.)-333.6(Infect.)-336.7(Dis.)-336.1(46:12541263.)]TJ -1.2503 -1.1223 TD [(2.)-500.4(Towner,)-285.4(K.J.)-287.8(2009.)]TJ /F4 1 Tf 9.3257 0 TD (Acinetobacter)Tj /F5 1 Tf 5.6357 0 TD [(:)-286.2(a)0(n)-285.1(old)-286.5(friend,)-283.7(but)-286.5(a)-284.9(new)]TJ -13.7111 -1.1284 TD [(enemy.)-338.1(J.)-328.7(Hosp.)-336.8(Infect.)-336.7(73:355363.)]TJ -1.2503 -1.1223 TD [(3.)-500.4(Wachter,)-379.7(K.)-379.9(2006.)-378.8(Step)-373.1(aside,)-379.8(MRSA,)-381.2(here)-377.3(comes)]TJ /F4 1 Tf 22.5977 0 TD (Acine-)Tj -21.3473 -1.1284 TD (tobacter)Tj /F5 1 Tf 3.3424 0 TD [(.)-335.5(OB.)-336.1(GYN.)-334.6(News.)-336.5(January)-334.1(15.)]TJ -4.5927 -1.1223 TD [(4.)-500.4(Ur)20.2(ba)19.9(n,)-299.1(C)13.4(.)0(,)-292.9(N)0(.)-294.6(M)0(a)14.5(r)0(i)22.4(a)0(n)19.9(o)0(,)-299.1(J)12.9(.J)19(.)-305(R)13.4(ah)13.8(a)14(l)0(,)-298.5(E)0(.)-294.9(T)0(a)18(y)0(,)-293(C)13.4(.)-305(P)0(o)21.2(n)0(i)18.6(o)0(,)-293(T)0(.)-294.9(K)0(o)16.4(-)]TJ 1.2503 -1.1284 TD [(pr)21.8(iv)18.6(nj)18.6(ak)19.9(,)-347.7(a)14(nd)-335.7(J.)-334.8(We)15.6(i)12.6(s)0(s)13.7(.)-341.6(20)18(01)24.1(.)-347.7(P)0(o)21.2(l)0(y)18.6(m)12.5(yx)18(in)-335.2(B-)17(re)17.6(s)12.9(i)0(s)19.5(t)0(a)20.5(n)0(t)]TJ /F4 1 Tf 21.3961 0 TD [(Ac)18(in)18.6(e-)]TJ -21.3961 -1.1223 TD [(t)12.6(o)0(b)18(a)0(c)19.9(t)0(e)14.4(r)-163.9(ba)24.1(um)16.4(an)18(ni)24.7(i)]TJ /F5 1 Tf 7.8009 0 TD [(cl)14.4(i)12.6(n)0(i)18.6(c)0(a)15.7(l)-164.2(i)12.6(s)0(o)18.9(l)12.6(at)14.4(e)-162.9(s)0(u)18.9(s)12.9(ce)15.7(pt)18.6(i)12.6(b)0(l)18.6(e)-162.9(to)-158.3(re)17.6(c)14(o)0(m)18.4(b)0(i)18.6(n)0(a)19.9(n)0(t)]TJ -7.8009 -1.1284 TD [(BP)16.4(I)-411.1(a)0(n)19.9(d)-414.9(ce)15.7(cr)17.6(op)24.1(in)-408.4(P1)21.2(.)-414.8(A)0(n)16.4(t)12.6(im)19(ic)20.5(ro)15.7(b.)-402.8(Ag)16.4(en)19.9(t)12.6(s)-420.1(C)13.4(h)0(e)19.9(m)0(o)18.4(t)0(h)18.6(e)0(r)17.6(.)-414.8(45)24.1(:)]TJ T* [(99)18(4)24.1(99)18(5.)]TJ -1.2503 -1.1223 TD [(5.)-500.4(Go)]TJ 2.0554 .0183 TD ()Tj .4147 -.0183 TD [(ttig,)-334.4(S.,)-338.6(T.M.)-337(Gruber,)-340.7(P.G.)-334.3(Higgins,)-342.2(M.)-334.9(Wachsmuth,)-341.6(H.)]TJ -1.2198 -1.1284 TD [(Seifert,)-503.8(and)-504.8(V.A.)-503.7(Kempf.)-508.6(2014.)-500.8(Detection)-507.8(of)-502.7(pan)-504.8(drug-)]TJ 0 -1.1223 TD (resistant)Tj /F4 1 Tf 3.8791 0 TD [(Acinetobacter)-536.4(baumannii)]TJ /F5 1 Tf 10.9847 0 TD [(in)-530.3(Germany.)-537.5(J.)-536.1(Anti-)]TJ -14.8638 -1.1284 TD [(microb.)-335.8(Chemother.)-333.1(69:25782579.)]TJ -1.2503 -1.1223 TD [(6.)-500.4(Goic-Barisic,)-401(I.,)-393(B.)-395.3(Bedenic,)-396.1(M.)-395.9(Tonkic,)-396.8(S.)-393.5(Katic,)-400(S.)-393.5(Ka-)]TJ 1.2503 -1.1284 TD [(lenic,)-361.8(and)-358.4(V.)-361.6(Punda-Polic.)-358.6(2007.)-360.5(First)-357.7(report)-362.9(of)-356.4(molecular)]TJ 0 -1.1223 TD [(characterization)-857.5(of)-850.4(carbapenem-resistant)]TJ /F4 1 Tf 18.3404 0 TD (Acinetobacter)Tj -18.3404 -1.1284 TD (baumannii)Tj /F5 1 Tf 4.7391 0 TD [(in)-457.2(different)-454.7(intensive)-458.5(care)-460.8(units)-456.1(in)-457.1(University)]TJ -4.7391 -1.1223 TD [(Hospital)-333.7(Split,)-337.4(Croatia.)-332.6(J.)-334.8(Chemother.)-339.2(19:462464.)]TJ -1.2503 -1.1284 TD [(7.)-500.4(Kaliterna,)-498(V.,)-489.8(M.)-493.5(Kaliterna,)-498(J.)-487.3(Hrenovic,)-494.8(Z.)-496.1(Barisic,)-490.3(M.)]TJ 1.2503 -1.1223 TD [(Tonkic,)-628.6(and)-626.8(I.)-624.7(Goic-Barisic.)-632.8(2015.)]TJ /F4 1 Tf 15.8763 0 TD [(Acinetobacter)-634(bau-)]TJ -15.8763 -1.1284 TD (mannii)Tj /F5 1 Tf 3.2326 0 TD [(in)-451(Southern)-455.3(Croatia:)-454.1(clonal)-453.4(lineages,)-457.1(biolm)-453.5(for-)]TJ -3.2326 -1.1223 TD [(mation,)-332.9(and)-334(resistance)-340.9(patterns.)-333.2(Infect.)-336.7(Dis.)-336.1(47:902907.)]TJ -1.2503 -1.1284 TD [(8.)-500.4(Public)-555.8(Health)-564.7(Collegium)-557.1(Committee)-560.9(for)-554(Antibiotic)-559.4(Re-)]TJ 1.2503 -1.1223 TD [(sistance)-675.7(Surveillance)-674.7(in)-664.5(Croatia.)-674.2(2015.)-671.6(Antibiotic)-669.2(Re-)]TJ 0 -1.1284 TD [(sistance)-450(in)-451.1(Croatia,)-448.5(2014.)-445.9(Croatian)-448.6(Academy)-453.9(of)-447.9(Medical)]TJ 0 -1.1223 TD [(Sciences,)-336.7(Zagreb.)]TJ -1.2503 -1.1284 TD [(9.)-500.4(Goic-Barisic,)-364.4(I.,)-362.5(J.)-365.3(Hrenovic,)-360.6(A.)-361.7(Kovacic,)-368.5(and)-364.5(M.)-359.3(Seruga-)]TJ 1.2503 -1.1223 TD [(Music.)-307.8(2016.)-311.7(Emergence)-314.7(of)-307.6(oxacillinases)-313.5(in)-304.7(environmental)]TJ 0 -1.1284 TD [(carbapenem)-439.1(resistant)]TJ /F4 1 Tf 9.0635 0 TD [(Acinetobacter)-438.8(baumannii)]TJ /F5 1 Tf 10.7834 0 TD (associated)Tj -19.8469 -1.1223 TD [(with)-336.5(clinical)-334.7(isolates.)-335.5(Microb.)-335.5(Drug.)-333.9(Resist.)-336.4(22:559563.)]TJ 25.2569 67.8052 TD [(10.)-500.5(Hrenovic,)-397.2(J.,)-402(I.)-399(Goic-Barisic)7.7(,)-402.6(S)0(.)-393.5(Kazazic,)-401.3(A.)-398.2(Kovacic,)-399(M.)]TJ 1.7505 -1.1223 TD [(Ganjto,)-475.2(and)-474.3(M.)-475.2(Tonkic.)-476.1(2016.)-470.3(Carbapenem-r)6.7(esistant)-475.7(iso-)]TJ 0 -1.1284 TD [(lates)-238.9(of)]TJ /F4 1 Tf 3.1472 0 TD [(Acinetobacter)-231.5(baumannii)]TJ /F5 1 Tf 10.3748 0 TD [(in)-237.6(a)-236.1(municipal)-233.2(wastewater)]TJ -13.522 -1.1223 TD [(treatment)-331.3(plant,)-327.1(Croatia,)-332.6(2014.)-323.9(Euro)-334.1(Surveill.)-326.1(21:2130.)]TJ -1.7505 -1.1283 TD [(11.)-500.5(So)15.1(us)25(a,)-181.3(C.)19.4(,)-189.1(J)12.9(.)-189.1(B)0(o)19.3(t)12.6(el)14.4(ho)24.1(,)-189.1(L)0(.)-179(S)0(i)21.8(l)0(v)18.6(a)0(,)-181.3(F)0(.)-173.9(G)0(r)20.2(o)0(s)18.9(s)0(o)18.9(,)-189.1(A.)-178.7(Ne)18.3(m)12.5(e)0(c)15.7(,)-189.1(J)12.9(.)-189.1(Lo)22.2(pe)13.8(s)12.9(,)]TJ 1.7505 -1.1223 TD [(an)13.8(d)-518.6(L)0(.)-508.3(P)0(e)17(i)12.6(xe)19.9(.)-518.5(2)0(0)18(1)0(4)18(.)-518.5(MA)17.2(LD)20.6(I-)19.5(TO)20.6(F)-521.5(M)0(S)-508.7(a)0(n)19.9(d)-524.7(c)14(h)0(e)13.8(m)12.5(om)18.4(et)20.5(ri)16.3(c)]TJ 0 -1.1284 TD [(ba)13.8(s)12.9(e)0(d)-657.1(i)0(d)18.6(e)0(n)19.9(t)12.6(i)15.7(ca)21.8(ti)19.2(on)-659(of)-655.2(th)18.6(e)]TJ /F4 1 Tf 12.1253 0 TD [(Ac)24.1(in)18.6(et)14.4(ob)24.1(ac)19.9(te)14.4(r)-664.1(c)0(a)19.9(l)0(c)20.5(o)0(a)18(c)0(e)15.7(t)12.6(ic)20.5(us)]TJ /F5 1 Tf 11.5154 0 TD (-)Tj /F4 1 Tf -23.6406 -1.1223 TD [(Ac)18(in)18.6(et)20.5(ob)18(ac)19.9(te)14.4(r)-322.5(b)0(a)18(u)0(m)16.4(a)0(n)24.1(n)0(i)18.6(i)]TJ /F5 1 Tf 10.3748 0 TD [(co)19.9(m)12.5(p)0(l)18.6(e)0(x)-321.7(s)12.9(pe)19.9(ci)14.4(e)14(s)0(.)-316.5(I)0(n)15.7(t)12.6(.)-329.4(J)12.9(.)-329.4(M)0(e)20.6(d)0(.)-317.4(M)0(i)19.3(-)]TJ -10.3748 -1.1284 TD [(cr)17.6(ob)18(i)12.6(o)0(l)18.6(.)-244(30)24.1(4:)18.6(66)18(9)24.1(67)18(7.)]TJ -1.7505 -1.1223 TD [(12.)-500.5(Villalo)]TJ 4.1292 .0366 TD ()Tj .4147 -.0366 TD [(n,)-311.3(P.,)-308.1(S.)-308.1(Valdezate,)-315.6(M.J.)-309.9(Medina-Pascual,)-312.3(V.)-312.9(Rubio,)]TJ -2.7935 -1.1284 TD [(A.)-379.9(Vindel,)-371.5(and)-376.7(J.A.)-379.3(Saez-Nieto.)-377.8(2011.)-372.7(Clonal)-374.7(diversity)-377.3(of)]TJ 0 -1.1223 TD [(nosocomial)-788.1(epidemic)]TJ /F4 1 Tf 9.8808 0 TD [(Acinetobacter)-786.5(baumannii)]TJ /F5 1 Tf 11.4788 0 TD (strains)Tj -21.3595 -1.1284 TD [(isolated)-336.3(in)-335.2(Spain.)-336.7(J.)-334.8(Clin.)-333.6(Microbiol.)-334.8(49:875882.)]TJ -1.7505 -1.1284 TD [(13.)-500.5(European)-879.9(Committee)-884.1(on)-872.5(Antimicrobial)-883.1(Susceptibility)]TJ 1.7505 -1.1223 TD [(Testing.)-358.9(2014.)-348.3(Clinical)-353.6(breakpoint)-358.7(tables.)-355(EUCAST)-350.9(Read-)]TJ 0 -1.1284 TD [(ing)-335.3(guide.)-333.8(Version)-337(4.0.)]TJ -1.7505 -1.1223 TD [(14.)-500.5(Clinical)-390.2(and)-382.8(Laboratory)-387.9(Standards)-391.6(Institute.)-389(2013.)-378.8(Perfor-)]TJ 1.7505 -1.1284 TD [(mance)-360.6(Standards)-361.1(for)-358.8(Antimicrobial)-364.7(Susceptibility)-356.7(Testing:)]TJ 0 -1.1223 TD [(23rd)-484.7(Informational)-490.9(Supplement,)-487(M100-S23.)-487.6(Clinical)-487.8(and)]TJ 0 -1.1284 TD [(Laboratory)-339.1(Standards)-336.7(Institute,)-334.1(Wayne.)]TJ -1.7505 -1.1223 TD [(15.)-500.5(Woodford,)-473.8(N.,)-471.5(M.J.)-474.5(Ellington,)-470.6(J.M.)-474.5(Coelho,)-472.9(J.F.)-472.1(Turton,)]TJ 1.7505 -1.1284 TD [(M.E.)-355.3(Ward,)-359.2(S.)-350.8(Brown,)-357.1(S.G.)-352.6(Amyes,)-359(and)-352.3(D.M.)-355(Livermore.)]TJ 0 -1.1223 TD [(2006.)-409.3(Multiplex)-411.1(PCR)-409.3(for)-413.7(genes)-410.8(encoding)-405.5(prevalent)-411.6(OXA)]TJ 0 -1.1284 TD [(carbapenemases)-434.2(in)]TJ /F4 1 Tf 8.1486 0 TD (Acinetobacter)Tj /F5 1 Tf 6.0565 0 TD [(spp.)-420.5(Int.)-423.1(J.)-420.2(Antimicrob.)]TJ -14.2051 -1.1223 TD [(Agents.)-340.7(27:351353.)]TJ -1.7505 -1.1284 TD [(16.)-500.5(Magiorakos,)-369.9(A.P.,)-358.7(A.)-367.7(Srinivasan,)-360.8(R.B.)-363.8(Carey,)-370.1(Y.)-361.6(Carmeli,)]TJ 1.7505 -1.1223 TD [(M.E.)-483.4(Falagas,)-490.9(C.G.)-482.5(Giske,)-480.9(S.)-485(Harbarth,)-484.9(J.F.)-484.3(Hindler,)-483.8(G.)]TJ 0 -1.1284 TD [(Kahlmeter,)-333.5(B.)-328.3(Olsson-Liljequist,)-329.7(D.L.)-327.2(Paterson,)-324.5(L.B.)-330.4(Rice,)]TJ 0 -1.1223 TD [(J.)-316.5(Stelling,)-317.1(M.J.)-309.9(Struelens,)-317.9(A.)-312.9(Vatopoulos,)-316.3(J.T.)-312.5(Weber,)-320.9(and)]TJ 0 -1.1284 TD [(D.L.)-363.8(Monnet.)-357.6(2012.)-360.5(Multidrug-resistant,)-366(extensively)-365.4(drug-)]TJ 0 -1.1223 TD [(resistant)-551.4(and)-547.5(pandrug-resistant)-549.2(bacteria:)-549.4(an)-547.3(international)]TJ 0 -1.1284 TD [(expert)-248.9(proposal)-244.1(for)-242.9(interim)-243.3(standard)-242.2(denitions)-243.8(for)-242.9(acquired)]TJ 0 -1.1223 TD [(resistance.)-341(Clin.)-333.6(Microbiol.)-334.8(Infect.)-336.7(18:268281.)]TJ -1.7505 -1.1284 TD [(17.)-500.5(Goic-Barisic,)-681.5(I.,)-673.5(K.J.)-672(Towner,)-681.9(A.)-672.7(Kovacic,)-673.4(K.)-678.8(Sisko-)]TJ 1.7505 -1.1223 TD [(Kraljevic,)-266.2(M.)-255.6(Tonkic,)-256.5(A.)-258(Novak,)-262.8(and)-254.7(V.)-258(Punda-Polic.)-261(2011.)]TJ 0 -1.1284 TD [(Outbreak)-311.8(in)-304.7(Croatia)-308.1(caused)-305.4(by)-305.2(a)-303.2(new)-305.1(carbapenem-resistant)]TJ 0 -1.1223 TD [(clone)-703.9(of)]TJ /F4 1 Tf 4.4097 0 TD [(Acinetobacter)-707.2(baumannii)]TJ /F5 1 Tf 11.3141 0 TD [(producing)-702.6(OXA-72)]TJ -15.7238 -1.1284 TD [(carbapenemase.)-343.5(J.)-334.8(Hosp.)-330.7(Infect.)-336.7(77:368369.)]TJ 9.2951 0 0 9.2951 313.0582 327.6849 Tm [(18.)-500.5(Ferreira,)-596.5(A.E.,)-583.4(D.P.)-590.4(Marchetti,)-593.3(L.M.)-587.1(De)-585.5(Oliveira,)-591.2(C.S.)]TJ 1.7505 -1.1284 TD [(Gusatti,)-303.1(D.B.)-293.5(Fuentefria,)-301.1(and)-291.3(G.)-300.7(Corc)]TJ 14.8638 0 TD .0513 Tc (a)Tj .4452 .0122 TD 0 Tc ()Tj .3842 -.0122 TD [(o.)-299.1(2011.)-293.4(Presence)-296.8(of)]TJ -15.6933 -1.1223 TD [(OXA-23-producing)-316.5(isolates)-311(of)]TJ /F4 1 Tf 12.662 0 TD [(Acinetobacter)-310.8(baumannii)]TJ /F5 1 Tf 10.5334 0 TD (in)Tj -23.1954 -1.1284 TD [(wastewater)-643.8(from)-639.1(hospitals)-636.3(in)-640.1(southern)-634.4(Brazil.)-643.5(Microb.)]TJ 0 -1.1223 TD [(Drug.)-333.9(Resist.)-336.4(17:221227.)]TJ -1.7505 -1.1284 TD [(19.)-500.5(Lopes,)-481.7(B.S.,)-477.8(M.H.)-477(Al-Agamy,)-479.6(M.A.)-477(Ismail,)-480.7(A.M.)-477(Shibl,)]TJ 1.7505 -1.1223 TD [(A.A.)-412.2(Al-Qahtani,)-416.2(M.N.)-409.9(Al-Ahdal,)-412.3(and)-413.3(K.J.)-409.8(Forbes.)-412(2015.)]TJ 0 -1.1284 TD [(The)-714(transferability)-713.3(of)-710.1(blaOXA-23)-713.4(gene)-710.4(in)-707.2(multidrug-)]TJ T* (resistant)Tj /F4 1 Tf 4.0438 0 TD [(Acinetobacter)-695(baumannii)]TJ /F5 1 Tf 11.3019 0 TD [(isolates)-701.4(from)-694(Saudi)]TJ -15.3457 -1.1223 TD [(Arabia)-335.9(and)-340.1(Egypt.)-331.5(Int.)-331.6(J.)-334.8(Med.)-333.3(Microbiol.)-334.8(305:581588.)]TJ 9.843 0 0 9.843 441.014 192.5291 Tm [(Address)-337.6(correspondence)-337.8(to:)]TJ /F4 1 Tf -.6048 -1.1116 TD [(Jasna)-334.8(Hrenovic,)-339.1(Prof.)-337.3(dr.)-333.7(sc.)]TJ 2.5458 -1.1174 TD [(Department)-337.7(of)-330.6(Biology)]TJ 1.7567 -1.1116 TD [(Faculty)-339.8(of)-330.6(Science)]TJ -.9158 -1.1116 TD [(University)-337.9(of)-336.4(Zagreb)]TJ 1.3247 -1.1174 TD [(Rooseveltov)-340.6(trg)-331.5(6)]TJ -.1958 -1.1116 TD [(Zagreb)-330(HR-10)-7.5(000)]TJ 4.2679 -1.1116 TD (Croatia)Tj -11.5309 -2.1253 TD (E-mail:)Tj /F5 1 Tf 3.3925 0 TD [(jasna.hre)-9.9(novic@biol.pmf.hr)]TJ /F8 1 Tf 8.9663 0 0 8.9663 62.022 749.6502 Tm (496)Tj 44.1086 0 TD [(GOIC-BARISIC)-334.3(ET)-338.7(AL.)]TJ ET endstream endobj 44 0 obj <>stream 8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0 b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup` E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn 6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O( l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~> endstream endobj 45 0 obj <>stream 8;Z\7D&.dI#itt$j?!1H/b9&U"Lh\t5:k&e"r.km@0BCNc;ko!PZBh)tG"o*P_)kih S*_!$FHi7%uk[MA]gf#6*Ct/St/,o<$S^&MLClB BEK'S85u0%RE"p)`hN1J@,):X0R'C-[/fLn[W1TV(85ej2.^D>`QR8m-N]cXSgun+ +BrF`s-S)&QS_#R(:F#(eoRACD6pt3A*#c/nqcsLFk%&C;n4Kinn6F^clk``[^0ln _WI[=T~> endstream endobj 21 0 obj <>stream 8;Z\6gU2Yf%*LijLOHH=qfnZ)0/OqVG2h0HoE0U4Ef_U/8bBqhUe^.RIZ($a<.4?J gdLPR.,;hXG_4:@O&6#48]t5Q(Pbp-YKK#IC-V*pIPDLQD`#*p[>Muh42dli:7l_d 8WPO,pZB&m7V=qpmu(bbKsSEhO4nj'eE'dH\J@YB27tJkXkbcV]IJ4nIL3Yu/HgD0Ij-gOX bT#q:$ND2-bK8-]Vp`25Q`e/ErW6pg=L!=&8L']gCpnV6O0fYRcT&\N-F?l<`sc(4 U":m:dkQhVA%Hj\FV+2M(_cNGO*+!-TO5B[c&39BJe^d[/aGU`OGnH+%fBHOo>FMG]e%a0,AN*!5jWWo$LYf7hNNP*05$Dt?d_Dj=;HFLob4n0nFU%e?D f78.kqXr>-g2HmSB#.$F]^O#KX#DA[0_;Taptd\G/*4ELF5_6J$WpU3 endstream endobj 41 0 obj <>stream 8;Z\799o](#kS$3j>sWHSs&RPD9ZmS:&@Nk+Y)+gY>&gbHGOHZ0KO+kiO(4dS?rjgE@&QV!EenIsW4QfBBc+^nKKSJGb^C!*8TpCU@,3]BA7T91n2/oD2p1 O1)Q2o`4TeRCQ`V?QL]\\XWpSXg?ISE]'V"*t'p91Pa.2A4C5SL\W_d8Rkl`h!\$8 bj%oD@gO7lg9Ug7(2or/Kds%8qS@26m9HiBO/aHpJ\"uHdDE$JR0Q]:k060EZE#gSZ`[LhIErJ[P,s?j-^5=hBY>t G,niW$UW`@6i^ltP%%G0GF6+NMEPcZM$c>NHeNoQ!.?C endstream endobj 49 0 obj <> endobj 50 0 obj <>stream HUɎ8+t6c [LlA63")0(Xޫo?f7^7M]tC෬)7!1MXbww^ݠخ9XW[&?%;cnLv76Ka6k)1]ӿZm1UJAh8A?n\8ǃGbs\p)zMּZlS4wDFQ5 nmvdBou/lVEVZ 4:BeZaKl@.slv3qZ=iyG/a0CDNv)z9C!鋀\%o昣>ߞY@ #2 fT^f󃝪•3AfC'PQD7bLmMmy&5Rvp"^SiܡBkWwpqVzl0)4G6݅+T٧Ί[?ǹK4ցx@^/Po}H~pf-O~snAM1/90|2~&r|:y`U܇\D߸W3r\VtWпqgѝ[U)De#K!nFu [՚ JMىk8T Eb\[s# t31[(e1J9惘qYN㸱;hrlI'"Kfe4ɝm} NT>n}RW A (,-KC]h endstream endobj 51 0 obj <>stream HT6+t IQs PhzhP`MsmPT6JgDkc'hgÙ7qwvdr8)wo~i Vw mZ.8#9Dey"Uol2]Y ƨ$~O!{pՂX a bЇm\jKE5 ?`iGCoZSE&./AMJҚ1UT]x*pjbݔ`187e 9%2M<oChgE[xbcЊF%!a0=E@ E  8erL xs52Wrͺ!cE *PaؑzWIVopGNyۙIh]kFiL|"gW\`V[Bh %fGKeu)q ivOgx2I{O[Zޫ [&/fNr" D7|rcAA)$!&hxRξD>?JBY:_޳><(-i#9 GR }4 j-a_8pS'P(Pz+r Noi~ j]מ-a/q}~ usn7؃>$oE5@1"maMC3}3^T_ endstream endobj 52 0 obj <>stream HtTMo6W*,V$%R:0/ޒde D9Ϳ 7@7_w~Ot|Z壖Z'0StWo@7D Ms'Gb xߒO:F 'T#Dgv,\ovw{}UKW+=>1\ŕi>L) Hm˞ƣN:Ck ;G1w$ڎy#t@Z4V5lV7\0>W 3YXţp)Z+!-yJCmZ}vl0W7R j=azzFY¶Q?\Snƹx x%)2{{;d i?6BQ+={]ipPh6!-r#<f v)B6a{utlgB#~#TB56YjTpVLmIH1x@dW1VH%&-Mr#¼A4åTeӃ4QXJ7CvSqAǼ@A.ib5N%(iyë*Sm{Ij(o躴՚D˚Z)M[BZ}tH'X<4./,^Cԙ/I|[C`Ӟip[TC pb}{CC+0c4cbe4QݲunFiяr躲)ؗOR_Bv4~V[W_O 0| endstream endobj 53 0 obj <>stream H\UMo0Ac;qHD%${CYeU-Dj3ڞ{_}*;UK-ba'ktt|[VvRx *v꤭**%R ǪCgUb4Æj0Q?WGXى4JZq&GjJiA:w< |,-1J@#hm)YkhD]M ]: Af+a-AiX|A,]I#6Zi5Gq)"+e>dlXVZ#b!)+R6"LG'vFB5O9oWNHrk#1X+"b'_xޥMUhŴMPo31`wRQ۩E&r~jkX[L}4Y:x&H0Fp> ;@D!ΕuHPIʵ* A)CL7Hz `F86ސ, Ҁl!y{vdcx^!Y&1<ޤzZzߔrΒ  :s FV ^ rnaqVyN߅쎲7t8dq0pZG!Dkq:+ҸUl\˓}>өO\ 'T8?bPכkָm^8#APшKdw4g4!ܘu=&Q-Y0@:AgAsZ1/I#JOáϏi{wCx=[u/?+0 9X` -¯x>(n,aqغ* endstream endobj 54 0 obj <>stream HtTɒ6+x\CJU%9l.*~ߒn @~ˮ6Z˪sß;ʸաuCrxkd1wIܾ4#@SA^1ݝ B}-_c1O{aF-'^IR\?H=|>XRA5;OG?aNnLO`Tx rHa[ 'pgUpRV [{$(KN[rrc )zu1 H/Kag?|*@JVA]C(& 8ZNM+jZUıKj Hq?͡s?*^0R00OKǫ-XA~:U+*nU>4d 9%ԈY :SBSY{BL~3>XxM^|$G0PbJ i}?yTXK)&^m-RzٙQ bLJG%Hgp1 Bʃ& ".x†El&/2?wxJrݽL4Bv:쐧!4! &,Nn?`LBAU r^}w i\L`5m5+/͇ VF@a8@dé. 4]H" Ơ2 &q U'CLj._vX$*9ͬA^o+Z+T endstream endobj 55 0 obj <>stream HtUˎ6+tY"",|[@Md~6ߒjRxiͪb_Re֨w|NK-nCxp[VuoS81"i ?9ԟ9&iqI^$7^ITS!io^A"5RRF n:' N~sr+GwuRw?_C!qbp""cQ,=r3ğp ojو䧙(|tt"1[ʠMifc2.'sVuꪑQTQ[K*czHgpۉ算lmVYF~_Eg]ݯ:pE+m[*~3}7Qm6h1!afCt|<f43-!>eVEA쨈e=cqʙw`gD?IG1E:k}!%[H-6Mp ܟzm&~ɂHu`پϞ _ 0y|%o8b !a[;e9!q|-{(-UԣQay~jό6e8)Yln36W楇>֘0ۢxņa؟]i1F&{>[.#Nx^<t_xK(qrq[3h>stream hbd`ab`ddprsqvL) I{X/x*##+\502033t3*hmxĪP{ߏ=߻]1{Cۿ7(cZWpAL~~ݲGǽݓKsBx޽ǥOmKWg ݡe3ڽg]|҄Dɩ./λj㙻&;su]` EP6}. 6 o q9> endstream endobj 79 0 obj <>stream hTn E{b]!m6"śkmtqs9=F3_I# 8YuGֳ ߖsFB0K /uPAnåN~ 3H Gϯ*_7D3HJI@gX{s QnU$K3<-NW]6Q2ux_V!3~Rn endstream endobj 56 0 obj <>stream H|Tn:+d9|ˢmPzu.nTXA tcV؍Fkj/{62C^+b}]8v5;ZpuNLCPa`48ogh}{asOV67tX >8Sd̐21͒gP`@{{ɭ.Ca"(abF6ZŊ)zNX/kSK5ܭfTT!H! OqzHqKqƪT媛Ur04vE  =iь "bINr*F !k/Pަ!n]H88XdZY*i;q&tz1mvm~&X~jܣ?/bBv"4y&yCC[>!(GxM0Zת߸D07=!"< <ìyz `$пN.u)6Й(fU`B endstream endobj 57 0 obj <>stream HTN@}߯M_ mbZ10N+~_] EQU!33G@@1LV`", Sc@ K`p ʼnx )1 BJ^]>(]vg(λ j&%@tqFojYh8ڐzCڴe^=5V M W,-oeMruQ>Cb.+#o\"§6X>.e:8]]w^eDZƪ1O:m]G`ABDT?=6fa ~7M>stream htWyTSsk m_sXZUc-*]5/?;eƃWdܝ5S7s|aZjv4) em%"O0{<0g h&.#hȗʎ], ~YY6N鱎Ejz% h4koPL@(7/O#)8}3VJ( PEL\A.=(!;;ӥ4q_aF&&S3ތYfL/_o ,Ƽ m[@df,h% p2G6l(pZxf4aeInY7hs0ubNͥIF2q 8bNbSŅ =>Bqr+Q'_{_ƿ[ Gv L֫uwY&*@.TK[ |<;ՠ~5 dgHx =|fcG.IR_'NbeulN#( ɏ(u-Nz07.&fQedBviVAX/OZj, s mI/G~xxi5a1B;?&σ Vɲvh^[ArqF47#rFZw;l=A_LRoqށhCy qؾ;R0h?C>歅Ep!Uar0yü΋I|ŜDrJLd&S0p_ U12o `1j٧DSeE5~MfˡMh~Bd6A+4Z9(W1vM-؊FAIl/Uʫh%I&\g|DO}]v\%i}+vݽ*|k!VB/ GMlytܪ;4M T ^t˔6-$/Os~CjE͍{n|< -lcelƧS?`j6YҐ/ଂ0VH (m)<2:kh,Lx1#2Za] G@0U>GN曥#}wS3ǐӏtE,Y$sR.BAIhNǿp:zuFRVjTIS&Ϲ~?ceTTIjyࣷԅqC1%e I$6{hI>HoJ.7 kmey5^n'2piRQ) )E~~n܈&rn7c@q(8WD]'lDTZ»{`WarJbʌ0cL#~6,% endstream endobj 69 0 obj <>stream htXiXgPcPTaĨ "-[F7k{C7,h}Ǩl3'ɜb>r[s}&{aGGG[|6/' }#Dюo8(!4m0ѱisr4->6N^Xh|=yF%GD핦n>G"REQ<nib+O$:->-M- OKtKq?,Dyns ?$9-]zFDz|T|xZ|tp1&;̠<),CCa_ q|\U811Qs1ǔ;ul±?8.i\/5$$DvZT6q|&?4&moO6z҈`w' '{sAo4e)_O j~o6}Za!55=rzdKK箄hD&RFpDfl-Lza6IJU[|R#_Q01"z%(TY<*Fwιw GzMy-VڬUQ^ OdvcXxݦ?c%lƭA0_-dGPT#{sZJ c0 FD+ g0-f=%!(ӗؾrK0Evnv*qr|Br-svfʧ;H!p1Wϱ~wլ8 8$Rh; PE0==WJ@ak@sg!,4w}XqySy9[M #QUmFG/k8čH <ԖᾫC=fh MXc_F̅/;#9>'-"i9M=Q}Ncb?zL I(9(X049A4rc' m/5u+\jTF&&32`/\(Ϯ'^5ny=1wwuU>vүRӡ:'OXw$ Np:.c*Q8 N NM|:LHi- MX}^l+5)Umk;-j3Ou2J]Ӟ4LouhLE(AQG`y|36`#LY撉Q$,i(U*i:' A`RTŞXXqVUI0(%Fym|Jm8>N~QhQyR~JR=' _ /eĩ?5X ͖ !}EpT͞I&쑚1ehc-z4hم:#\ OKЫ3wU݈֢IH>?›F+ńIdMERuj;0x, y^jg8Õ' B#gQTP*-*Bd6S/fnlZB'N#DU֑B4F ,>Y*׸6B{eC]gal6IMk틯(d$1tބxbc4ӃFys3o[b#]6˔Ydfkr*V5rNR)~S][EDV6d&`0{[F<b < A5FqșZ4v{/4׏,,wZ'|m~9C _WcNA\BŒvb6wΏSYN qo @ ? pOczc;{&>xo\1mɝ%[*%,/j4Td3_nȄbyͮhVҭ0R?iS#)H'현n_ϒggfVUߦ`7RXw .~V.m\( L.~wnכ>.r!+0ě49ð Kth>Jj8rBIsM\(uԈC~a}o>Ċ jFl2Fq3GO`Jqt?|/fQ#{q4Vdϑ@* /"_q U. m0f(v`1wgPoūUk9 .!}hGL W>ڕ:n {NgkբݻeK"a/XAu?? yHˆ5zLCf,u0γ\]Q4v +M*M+@6)S6/@&Zm00=5v"5w$HgY$sP#:'A<⟸;^e ؝WBmRV*?%&FA[gښ ivISVtm"6hDwF,3(kR{ k׎^/rSd;Nr~ŬD&ڀ7*LRQ_1 O +[Ell8[4PEeSYp&B*Ist̑![鮸 2|rV#vEAHyerg)S[Tg_mWPffVX?>{cWѠ4 k#ڣ7#Ҽzؕr2Գ ,@I -\YpVUNIXg KɠÛ[mIlqFqFMjѵXmkjz:5j'U}ϯ ~'K26/*=|:߾yЙm%,,@Z_7@qWLbR/&h)ў Ѹ@a)vf5<ㅰN-*0="z zsډ}¬@w),$Tz~RRb?H4cE.2CEƪֽ[e=@7\ *+Ĩk v';j;1C9 4Ngmas; fFcܶ.' 9M'RcFf{CkJܢjU2Aq#xa/՗k˺V BLT:#Sܫ/rBn%Tq\^+dWu7Ħ|IV"HRbxN_lfQ0^Vq`Xfu ߀Qh Ie XUe6:YN ))$v44e4 MH&6pZ"VbNKN98\(6fJzgȶ{L?^Wo|*O;Ln@z :iV"ΐ` ECvɉD!"W]_br>"JCG ~vt134xȏ}@Ce2XZפByоT4eUwQM렯bQ4!UcaVY(0٫5/:.4yOC-wDrp@f/z5H||g/>D3XL.k ^J$v,Qp_,fFQ` B,RC_jAPVЦe}OFudC*FS1A l5lډm-ġry% lzF@STUQ߿I}+w_{}9|D1| ɳMLSy\d5weGgzd_y@Je#u~ĸ 7Bx 5\YR]=^ϋ1ƱҺD<~y#GKb6~>㸶9\b 먖'Og7Oa)osx,31(1j:<HMSfK3 N"\YrVK]F֚őR 9yLF0KH~pOМ,C{TBEČǢas_?sAC} CJ[3u "* -_̆2LSZ`LMFƊD*)v:W 蒲 +%&{!D0Rd1PHۭZUC)uE1-E!.0͍DTY4%RSBU򩍃oP6g1ҥjXQy}}x4+U J[d?VBfH1D_F QZqjE FרSg$RZC2Tv}f y$fiS4 ZR_\<ɘKVG 9*W¬CibLS_]E >stream h,M9oj0B'j~jK1L_|T31IU*U^mq{7 3 ݭ.& syK9;󻋝n<~Yf/8ǧo.=ׄ8ſ%ώ'$`U~X.C^2Dtw58M;A L4 K_E[?%[>B}5pg\4GVZ-'=v7}z{9ѾK^ 0_gyђV&l͡HTҬu-pM[ԭ;@"#+\ w}Lq1Eʃ x ŏ}~=֘c_fx ^cc?O6 mʲ9o^=i`86ʺq԰zx(G1)q}.lisK'h)Uڑh?y3u$MPsς6w.5>$PH&AB`Dg|͒2)Q^zG=I)צЂjf&y, $C8XIE< +,D"X(Y.FRb &ȋMHrɦGڬUT]f)G0.cvWHN( AqKTCPj]2S~rW8ܸ  endstream endobj 74 0 obj <>stream hlSkPWً_]f֊B)JAyDLIH HE!ᑐ iT-:TVccN+̷xәnqs"$H$I˓RY*ڕu3"DǪ5R0OSӈ `4śldlv^|ܻQ|%0~.T/TLQٔ"=gsJZòKZ6;j^͕DͳUFNR\ ĮԔ&]*KUzՈ{|Y!QiFiEDQD XNd"XKL B R #$B"9$z\<2Vƞ  Q/h=#TdB aH}{7p ?Ҭ*D$o\ )WQ;&r*Q:Ԁd} @iZkv-Á߃ًlP`ZGbpdբ$< Tg9H|Ÿa2)[-GWouqV-F!DL 10HrÖΓc-fB!'.} nv3P9E˴P6 ~ʡ3ցWUub(CmmUvA!asgš}F``JSt6,*>(*#Ē(ٽxLo7YŁ{*~ѝ#9~-.RѺΪ\گGYvfshAmC`ߑH O6RjF2m_h:.Ѱa W /ϐGGDø_W@:Z`P!cSE6yWz#qG:ڷ+s2-&m3<2Vlސ)*mU4ikv^y8Շ\a724꺽EJwr}Fm^Uoݷw_C خ6]Կ 5+ endstream endobj 75 0 obj <>stream hdV TS} y7q+{"*ibEyLHd_S*VNEApXhCZŪ_AZמGOgյ:Yws׹>EhԌJ76ďɼJ{M;Xpv-*^3jʵu#Й 5OO2/ס:tksXRRan=3Wpf;KUuE3P׸4aMq@4!Z^{C[kza{zOO8 9܋>XA`=G$-# c 1fO>4Z=̔qx dVw6~_=<6iz*% ^<؏D͡ 9^^#}VM5mⱤ#8 ҡ0y<0gX\~;)x?6mSO;(M=eɩ3LExCu'^|G,A1Є#@k:j+دd⌉c+RC_ؗHVc nxae!X3}Q!\`Xw`3.GvWw=5\j @OI\KD^X8iV^q{u<>X ```nCHDYQ<:`+е4%t o:X=/Sؕ@rLW"}yʍoSO܍FE2@|S柯SC l+E=̀k] |O]<\'TG/~cªQ=| TQle\` XtxI~PF`[yeMY X l`!J?wû&}Xs]\kxW ͛@ljdɄ8ɐ. &K;EoLAYC}V|a $Ua[1cHkg0W'v|*$Ka${= Q\9\ 23Mu] Z΀kxz@KVJ!049'I2 ^K$w8Ȥ= ӦCTd-'~$󩟭-Y9~.÷yLF(XL=Q)3~b*6#'{].O%ffXT$bl1S vG+,[ީUdI 7֜2>^y} 7r79sG.MT^\e(E8:>5G1fCzjHhRp}1d嘑NF4cP3>'bhE}mgvC›A 0Na" v[[@Ab+JWCҧNG2 ]#Gӌ7D 7,Iw$_Vٻ!;anj6jmu-H9; $z&l!ե3m%+I%="4yO#1=qϙ=o?jѯ5{b<ױQ $Qtr؛ļt.N[rO䖧cv Ft endstream endobj 76 0 obj <>stream hlT{TECkVff#_)AW AYtQ@v\vV, (",+"5hb9F!֘FmLmkMOwݞ٤{c7 bT*oErKW 2 2S z9vQɓdžBwv*'ΟT{z 636΋Y5+13W-ڠfvy""cY;[mݪ zX} Z¤ ȈhȀǾ c_LFUfU[S_Svw) jy,|I$a-@45݆`_QKj!9zÑ)%ܢ$y>=avWTRf'B'4) 7"ޣ+ 7]gh"[O*! 'c=e`L }D/:L&MRRx#~yԠ+3#.$;6SInoSG`@oEj]8Xi]Gt͚0M<|D::7S\9 Y_Pc4q7Dx@*Ѝ;) q1<0&zYATJArӕ%?AƸ;C`Z nD)6PT$sN\;eAJB8 gb)/7tei^X P^J;] 9`nllu~{Sⱼs쑣&*?sğL9{DUI6TK*q Iۚ~Jԯu+*v[ V~3 fᏁ`5wU1eW4Ry\M QV:Pw^C`մ=ʦjbO?˺ ,c:m=4ɍS$zzoF4SЇc[Q=nWBZYgFs`Q" endstream endobj 81 0 obj <>stream htV TW_-&jV5.ؠ,""AZYF Deh5. =j"QY$A Ũ+59S͜3s̩:޻-%VL&{;읈אܘI^H#mU_۷To9xe%VfdRek'OxYe҄d ؼlê,Mdzr13è6xh4!+Wjn Yc$iXkNKiҲ4:MQbX3d,Dgde4!34 &Mgi,@ɤzKA Sxr(w9S EE[Sr*b( AK[JC*K]n5+sVZXY*yTF+}Ȉl%PfT*b0H=8rеAOlF+Xu$ Dn0JsfM`"1e8X^a# w{! |y.8 L¤\Nt C$+b{H>QQpq{d #W >m1=.2F9f]W3͕KࠆaP٘'] lYyQwu>Dy5O>ȶ]_&+Œ}B1s/Ǒ!crqg=62s5EEkXlX 6Ҿp;!bf1#s6åhDRӑB7ٗV UT뚰ȐÛC0ѻx< ;6/rؤͼZ|rCqkStoL{VRggJN_4l2NdMSEpOǓR{snGR'9;L~cn璪jehWϖ~>[(0$"2'0嬟vxq9AuݸGq$$t}V ߂}0]8÷rNY)].Ji6҇sq(LAh_;'vb$qk;0I(,uMz M4a E=~T<;>-@"XJ q>{O[Ϝ.srWM6ho|;t]Nq1{$X_.5;Z_R.A%ln_k%+砠b:\b5WuOy֙YwJU^ ' LM~R"  N$;;$z(O@\ j [@pOUPURvX F[WٖcOIƂ|.2Q?{`zlPhX< Kөߝk·74~O"Q%RgKMjPvPgTf>stream hlPmLSW\Idw͹ J6|"ΐAgiv>R&CۮT7Ed,Sqq}X̩FܖIW#er}a( òC9y9dŽ-=7۸aʊ=͢t" 4Ƕݝ1 g;=%>Y$ef[afYK=NT !\%U6xoS%$U6_%$ZIt&Tg"Kqh[8dѪjNj3 >&a6i<)d S0,ë(c1rv;{b͐f)HB<'1# AB(Qz=sZ]x?$ct贗+'?$կZpV#bOSDZV/# endstream endobj 83 0 obj <>stream hT_ԟ`Ba('G _-o澪;2x$|-d^<f3 $9S}Mҝ\/Ua4Z /ͭH7/wh3}O63<Znj@%1?!?lF`>)=zzO.<+Ad10/y=x藓rƢ^W7b/&:樅9,^e.kx/ PM61,6zEk^1s,}qz.4)U!9F("-J`_w5^珄xX7dyx}B}77 H ̇M7`d< ϔc J+-k) L~VT^!rA'حY{ŔiL$)z֧P,`1-( /\ԫk1ti vMbnxGMptHc4Fl(+VqP)`b7yǺ4lpY^pT-: t8ue+MB Xt/@ a\6 -hLSx5Aqj" 澸拞sM57T5ps[G;[-5[O7j?8(}PSUpy%oj11YNE 3o{Kȡ-7f~kkwv Z %1P 8< ^\q=s$ qMj=h/6(|>pzV,2QK= V z !W_˾Id##1TOow1jEN,EapTgr #$IŸk`FJ:\I&;>9(F4!# XUb.>!aJ:8`$yzN(p`'hR3>W aUc8!dEjx)zVx{I]^F{v<_+ruuu҃Z*ml2,!\cw䂝If+uW_ Mrmg'q\؜Jiyּ5"9tODp!SX* fHs eO ~uƄ<<`pR|3{Rn a0+~P`=χpc)C"6ݶfYҳ( 'dtXtXMsMnK%6a fqт9kӎ =̫)P& *9&y cvTs2ȣ_u_$RW},L&UX]Ez6LI6@ endstream endobj 84 0 obj <> endobj 11 0 obj <>stream xZkO+qWGߥU%!q$ 3ǎYΌs{>ds\:s|KΜhA^\Ʉq`;܀30px"L0Ʌ`n2p/tCyx1 t#d0vC1138?PlFbP`jKeH8,,X7 M,@S(c! d$(|"Pw aL4I:}s_;Q?_p/P#%ժ_$<]Po2ϰ<<}.Ә>Ou8zty;4vx A||0Iʡ![Q4iRB3)h@ ZҴJ6‚m+_#& jmgI|/TV-uKRyu:WqvEYոqL>RrSP.55Tk;:5jE5#(d‡Â R+H/᭰@D4-@t4"\Ic@Y'Vio #Wj6 PVg✥ܗ=U@UAzeÎm^ /O[`++f@ZxVňx5Uz*_1fjtPgD5KQVwhLJXfwBO|me4X $N V^P#4)=Ypvn P 4>+^f^ wk~jV#k+W墼C"s,SMpO[9(N?xa}3b '94>:H5/m$y ٠^㛼D7N)Ԧwïs 1wn .|?;G8 !W bSGJH†}C[tdmTUF%\+{k7-".6F+gNZh"`b'nA"ےICD|;%$0DQT endstream endobj 85 0 obj <<70cab008149ab8db7bb582aed1536cb5>]/Root 49 0 R/Length 273/Size 86>>stream x-пJA..4ј&wыXh/`66) |!؉KX+|ŏavgY33`V5 "3Xn"ߡ5-iB #qƸHX~и`߳>ӂ |Tʲ5YӲ.e{}rOeǹH aCREVg4ZoZۧ_ЭI9%+rAf'rF6uYֲ֖ owtot<0٤G8:); endstream endobj startxref 101185 %%EOF